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Abstract      
 
This thesis discusses the construction and DNA-binding properties of homo- and 
heterometallic, oligonuclear complexes containing the [Ru(tpm)(dppz)]
2+
 moiety. 
Specifically it explores how the nature of the tether affects the binding properties of these 
systems. Towards these goals, four new connecting ligands that possess potential DNA 
recognition sites in themselves have been prepared. The ligands have also been chosen to 
investigate the effects of changes in connectivity and linker rigidity on the binding properties 
of these metallo-intercalators. A series of mononuclear complexes incorporating the new 
tether ligands N,N’-bis(4-pyridylmethyl)-1,6-hexanediamine (pyXapy), N,N'-bis(3-
pyridylmethyl)-1,6-hexanediamine (pyXbpy), pyYapy = N,N’-bis(4-pyridylmethyl)-1,4-
benzenedimethyleneamine, and (pyYbpy)= N,N'-bis(3-pyridylmethyl)-1,4-
benzenedimethyleneamine were first synthesized. These mononuclear complexes were then 
used to synthesize analogous dinuclear systems Figure 1. The DNA-binding properties of the 
mono- and dinuclear complexes were then explored and compared. 
 
 
Figure 1: New mono- and dinuclear Ru(dppz) complexes 
II 
 
A combination of techniques indicates that all the complexes bind to CT-DNA through 
intercalation. These studies have also shown that whilst complexes [1-4] clearly bind to CT-
DNA, complexes [5-8] bind with higher affinities. Furthermore, it seems binding can also be 
enhanced through the use of more rigid ligands pyYapy and pyYbpy.  
This thesis also reports the DNA binding and cleavage properties of heterobimetallic RuII-ReI 




 complexes - Figure 2. 
The cellular response of cisplatin sensitive and resistant A2780/A2780cis human ovarian 





system complex binds to duplex DNA by intercalation with good affinity and displays a DNA 
light switch effect but does not cleave DNA. The complex-DNA interaction is enthalpically 
unfavourable and entropically favoured. Moreover, although the molecule does not display 
significant phototoxicity (PI = 2), it displays significant dark cytotoxicity.  




 polypyridyl complexes with the dppn ligand produce a 
higher 
1
O2 quantum yield. This is due to long-lived ππ* triplet state centred on the dppn 
ligand. Thus these dppn complexes show high phototoxicity indices.  
 
 














The work in this thesis is the original work of the author except where specific references 
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degree. Some results have already been submitted to peer-reviewed journals and will be 
published subject to acceptance. 
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Dppz: Dipyrido [3,2-a:2’,3’-c] phenazine 
Phen: 1,10-phenanthroline 
Bpy: 2,2-bipyridine 
NN: Bidentate ligand 
AgNO3: Silver nitrate 
AgCF3SO3: Silver trifluoromethanesulfonate 
n
Bu4NCl: Tetra-n-butyl ammonium chloride 
Na2CO3: Sodium carbonate 
NH4PF6: Ammonium hexafluorophosphate 
NaBH4: Sodium tetrahydridoborate 
DCM: Dichloromethane 
DMF: Dimethylformamide 
TFA: Trifluoroacetic acid 
THF: Tetrahydrofuran 
EtBr: Ethidium bromide 
H33258: Hoechst 33258 
DNA: Deoxyribonucleic Acid 
VII 
 
CT-DNA: Calf thymus DNA 
RNA: Ribonucleic Acid 
TAE: Tris-acetate-EDTA 
           Tris: Tris(hydroxymethyl)aminomethane 
IL: Intraligand 
ISC: Intersystem crossing 
CT: Charge transfer 
LLCT:  Ligand to ligand charge transfer 
MC: Metal centred 
MLCT:  Metal to ligand charge transfer 
Kb: Intrinsic binding constant 
IC50: Half maximal inhibitory concentration 
ICP-MS:  Inductively coupled plasma mass spectrometry 
PDT: Photodynamic therapy 
PI: Phototoxic index 
LISA: Light Irradiation Source Apparatus 
ITC: Isothermal Titration Calorimetry 
COSY: Correlation spectroscopy 
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1.1 Nucleic acid (DNA) - The molecule of life                              
For more than 50 years, deoxyribose nucleic acid (DNA) has thrilled and inspired the 
scientific world, largely because its study is essential to the understanding of life. DNA is a 
chemical repository for the genetic information of an organism. The genetic information 
stored within DNA, in the form of four distinct building blocks, governs characteristics of 
every living species on earth. In recent years, the detailed mechanisms of DNA, and its 
function in the cell cycle, have been fully investigated.
1,2
  
The processes of transcription, translation and replication, which all involve nucleic acids, are 
known as the “central dogma of molecular biology”
3
 and are shown in (Figure 1.1). Through 
these processes, DNA can be simply copied, and important information can be passed on 
from generation to generation. This genetic information is sometimes changed, either as a 
result of reproduction - where the individual genetic characteristic is mixed from the parents - 
or as a result of a physical modification such as miscopying. These modifications are known 
as mutations and frequently trigger a cascade of events that can lead to the organism 
developing a disease state. One of the aims of genetic science is to gain control of DNA 
function at the molecular scale. In this context, an important goal is ‘gene modulation’ which 
is a process of selectively switching a gene on or off by using DNA binding agents. If this 
occurs in a gene which has a marked negative effect on an organism, it would be inestimable 





Figure 1.1: The central dogma of molecular genetics, DNA replication, RNA transcription and 
Protein translation. 




1.2 The DNA structure                                                                                                           
In 1953, James Watson and Francis Crick first described the structure of DNA
4
 as a linear 
polymer consisting of repeating nucleotide building blocks. Each nucleotide consists of a 
pentose sugar and a phosphate residue linked to a nitrogen heterocyclic base.
5,6
 There are four 
nitrogen heterocyclic bases in DNA; two of these bases are the purine derivatives adenine (A) 
and guanine (G), whilst cytosine (C) and thymine (T) are pyrimidine derivatives. The bases 
are linked to the sugar with a glycosidic bond, through N9 of a purine bases and N1 of a 
pyrimidine bases (Figure 1.2).  
                                                                                    
 
 
Figure 1.2: Nitrogenous base of DNA 
 
 
The polynucleotide chain is made by phosphodiester linkages between the 3’-position of one 
nucleotide and the 5’-position of the next nucleotide.
3
 Specifically the 3’-hydroxyl group of 
one nucleotide, esterified to a phosphate group, is joined to the 5’-hydroxyl group of the next 





Figure 1.3: The covalent structure of DNA 
 
When Watson and Crick described the structure of DNA in 1953, they made a proposal for its 
secondary structure, suggesting that wherever an A appeared it was always paired with T. 
Similarly G always seemed to be paired to C. This led them to suggest the idea of 
complementary strands held together by hydrogen bonds (Figure 1.4).                                  
                                                        
   




As a result the structure has a degree of flexibility, as hydrogen bonds are much weaker than 
the covalent bonds that define the structures of the bases themselves. To biochemical systems 
these weak bonds are crucial; they are weak enough to be reversibly broken, but when many 
form simultaneously, strong enough to help stabilize the DNA double helix.
7 
The 




C and G.  Two helical chains form from these complementary strands, running anti-parallel to 
one another and to create a double helix twisted around a common axis.       
The purine and pyrimidine bases are on the inside of the helix, and the negatively charged 
backbone (deoxyribose and phosphate) is on the outside (Figure 1.5). Stability between the 
adjacent purines and pyrimidines is created through π-π stacking interactions. Likewise, the 
polar sugar phosphate backbone forms favourable polar interactions with water molecules 
and cations.
8
 All these forces contribute to maintain the two-stranded double helical structure, 
which contains a major and minor groove.  
 
 
Figure 1.5: B-form structure of DNA. Showing the inside and outside double helix 
  
 
 1.3 The major and minor grooves                                                                       
A consequence of the DNA helical structure is that there are two helical grooves running the 
entire length of the DNA molecule called the major and the minor groove (Figure 1.6). The 
sizes of the grooves are different, with the major groove being wider (12 Å) than the minor 
groove (6 Å). In these grooves, edges of bases are exposed at the surface of the DNA and 






 The major and minor grooves differ in hydrogen bonding characteristics, steric effect, 
hydration and electrostatic potential.     
 
 
                                                                                                            
 




X-ray diffraction studies on heterogeneous DNA backbones carried out by Rosalind 
Franklin
10
 were essential in providing more understanding on DNA structure. There are three 
main possible duplex conformations of DNA observed in organisms, A-DNA, B-DNA and Z-
DNA (Figure 1.7). The first two conformations are right handed helices whilst the latter is a 
left-handed helix.
12
 It is known that under physiological conditions most DNA is found in the 
Watson and Crick B form.
11
 There are some obvious differences between these three major 
conformations of DNA in diameter, size, helical orientation and shape of the grooves. These 
different properties are summarised in (Table 1.1).
7,13














Figure 1.7: The main nucleic acid conformations 
 
 
Table 1.1: Main structural features of A-, B- and Z-DNA.
1, 12
 
Property A-DNA B-DNA Z-DNA 
Helix handedness Right Right Left 
Repeating unit 1 base pair 1 base pair 2 base pair 
Diameter ~23 Å ~20 Å ~ 18 Å 
Rotation per base pair 33° 36° 30° 
Base pairs per turn 11 10.5 11.6 
Helix rise per base pair 2.6 Å 3.4 Å 3.7 Å 
Sugar pucker C3’ endo C2’ endo C2’ endo at C    C3’ endo at G 
Major groove Narrow and deep Wide and deep Narrow and deep 
Minor groove Wide and shallow Narrow and deep Narrow and deep 
 




1.4 DNA Binding                                                                                                                        
There are several different mechanisms that allow small molecules to bind to DNA, and 
because DNA is fundamental to cellular processes it is an attractive target for therapeutics. 
These mechanisms will be described in this section.  
                                                                                                        
1.4.1 Irreversible Binding                                                                                                          
Non-specific covalent binding can occur by the formation of coordination bonds with either 
the phosphodiester backbone or sugar residues of the DNA helices. Irreversible binding can 
affect transcription processes, which usually ultimately causes cell death or alters gene 
expression.
14
 Drug molecules that bind to DNA in this way can bind to sites either in the 
same strand (intrastrand) or crosslink from a base on one strand to base on the 
complementary strand.
15
 Cis-diamminedichloroplatinum (II) is an example of an irreversible 
binding molecule, and is one of the most common anticancer drugs in the world (Figure 1.8). 
Cisplatin is used to treat testicular, ovarian, bladder, lung and stomach cancer. This drug 
forms intrastrand bonds to the DNA helix, through the N7 atom of either guanine or adenine 
base is binding to DNA.  The trans-isomer of cisplatin is not an effective chemotherapeutic 
agent, indicating that not every irreversibly bound molecule can have this effect.
16




Figure 1.8: Cisplatin DNA binding structure. Shown platinum atom as a white sphere and 





1.4.2 Reversible Binding                                                                                                            
A broad range of chemical species that includes water, metal ions and their complexes, 
proteins, and also small molecules, can reversibly bind to DNA.
8
 This includes many 
antibiotic, anticancer and antiviral drugs, which utilize their primary biological effects with 
nucleic acids by reversible interactions. These interactions can occur through three main 
modes; electrostatic interactions, groove binding interactions, and intercalation 17,18 (Figure 
1.9).     
                    
 
Figure 1.9: The three main modes of reversible binding of molecules to DNA. Showing a) spermine, 




1.4.2.1 Electrostatic binding                                                                                                      
The DNA molecule exists as a polyanion under physiological conditions, due to the 
negatively charged phosphate groups that run along the backbone of the structure.
5
 This 
means that cationic molecules are able to interact with the biopolymer. The stability of the 
DNA conformation is increased as a result of this interaction. The cations size can range from 




) to larger cationic polyamines, spermidine and spermine are 
typical biomolecules that employ this type of interaction
19,20
(Figure 1.10). 
                                                                                                                                                                             





              Spermine                                                                    Spermidine                       
Figure 1.10: Chemical structures of spermine and spermidine 
 
 
The counter-ion condensation effect caused by polyammines, such as spermine, reduces the 
nucleic acids effective charge and affects the solution properties, binding interactions, and 
stability of the biopolymer.
8
                                                                                                   
 
 
1.4.2.2 Groove binding                                                                                          
In B-DNA the major and minor groove afford appropriate binding sites through reversible 
van der Waals, hydrophobic and hydrogen binding interactions. Unlike other binding forms, 
groove binding can extend over many base pairs and therefore very high levels of DNA 
sequence can be specifically recognised. (Figure 1.11) shows the hydrogen bonding sites of 
A-T and G-C base pairs that are available in the major and minor grooves.
21
                                                                                                                    
 
 






Many proteins have evolved to display explicit groove binding interactions. Some proteins 
and many small molecules will interact with DNA through the minor groove as this provides 
better van der Waals contacts. Typically, groove binding molecules are polyamides with 
aromatic rings linked by bonds with torsional freedom so that they can twist and become 
isohelical with the curve of the DNA groove. The majority of these compounds bind 
selectively to A-T rather than G-C rich sequences because the groove is narrower in these 
sequences and therefore facilitate van der Waals contacts with the walls of the groove. Lower 
affinity binding to G-C rich sequence is due to the N2 amine group of guanine, which 
sterically inhibits the penetration of molecules into these groove regions. Furthermore, 
negative electrostatic potentials in A-T minor grooves are greater than in G-C minor 
grooves.
22,23
 As a consequence cationic molecules have a higher affinity for A-T sequences. 
To enhance G-C minor groove binding, ligands have to form hydrogen bonds with the 
guanine amine group. Groove binders are frequently positively charged, as binding will 
decrease the charge density of the DNA helix and thus condensed counter ion ions will be 
released.
24
 These effects are illustrated by the interaction of netropsin and distamycin with 
DNA.             
 
1.4.2.2.1 Netropsin and Distamycin                                                                                
Netropsin and its close relative distamycin have been extensively studied as typical examples 
of minor groove binders that favour A-T rich sites over sterically blocked G-C rich sequences
 
22,25,26
 (Figure 1.12). Probably as a result of their affinity for DNA, both pyrrole-amidine 
structures are antibiotics that have antiviral, antibacterial and antitumor activity.
25
 Netropsin 
and distamycin have more potential for recognising defined base sequences than do typical 
intercalators, which insert horizontal organic rings between base pairs adjacent to them. This 
is because intercalators basically detect only the base pair adjacent to them, while the groove 
binding drugs can extend for many steps along the level of the groove
 27
, vide infra.  
 
                                                                    
    





Figure 1.12: Molecular structures of Netropsin and Distamycin 
 
An X-ray structure of netropsin with C-G-C-G-A-A-A-T-T-C-G-C-G
 
showed the basis for 
the AT-specificity of a groove-binding drug complexed to DNA.
27, 28, 22
  Firstly, AT-base pair 
reading is accomplished under the aegis of non-bonded contacts between the C2 hydrogen on 
adenine and CH of the netropsin pyrrole or methylene groups. Secondly, AT base pairs can 
twist like propellers more than GC pairs with three hydrogen bonds, because an AT base pair 
has only two such bonds. This propeller twisting narrows the groove
 29
, and as a result the 
narrow groove strongly binds to a planar drug molecule. Thirdly, an absence of N2 amine 
group on adenine makes the groove deeper. Finally, in AT regions of the minor groove the 
electrostatic potential is deeper than GC regions, perhaps because of the absence of the same 
amine group
 30,31
 (Figure1.13, taken from references 25 and 33). Therefore like most groove 
binders these cationic drugs are more strongly attracted to AT regions. Both netropsin and 
distamycin can be seen as polypeptide chains in which every alpha carbon has been 
substituted by a five membered ring pyrrole ring. In such an augmented polypeptide chain the 
distance between pyrroles is approximately the same as the distance from one base pair to the 
next along the surface of a B-DNA minor groove.









                                                                                                                                                    
 
 
Figure 1.13:  X-ray crystal structures of netropsin (a) bound to d(CGCGAATTCGCG)2, (PDB ID: 
101D)
33 









) and high selectivity which is credited to the local short-range ligand 
DNA interactions rather than from any entropy driven process resulting from the 
displacement of ordered water from the minor groove and desolvation of the ligand itself.    
  
 
1.4.3 Intercalation                                                                                                 
In the early 1960s, DNA intercalation of ligands was first suggested by Leonard Lerman.
34,35
 
Intercalation is the process in which planar aromatic compounds insert and stack between two 
adjacent base pairs in the DNA double helix. This interaction includes significant π system 
overlap between the intercalated molecule and DNA bases, in addition to van der Waals and 
electrostatic interactions. Intercalation has the effect of unfastening and lengthening the DNA 
double helix. The binding affinity and selectivity of the intercalating ligand is extremely 
affected by the energetic cost of distorting the helix and disrupting the existing base pair 
stacks.
36
 Ethidium bromide is a typical example of a simple “pure” intercalator that shows 








DNA (Figure 1.14). In fact, most intercalators bind well to mixed sequences of alternating 
purine pyrimidine bases. Due to the principle of neighbour exclusion, in which the 
intercalative site narrows the gap between base pair “ladder rungs” on either side of it, 
binding site sizes are usually at least three base pairs.17        
 
                                                                                                       
 
Figure 1.14: Structure of ethidium bromide  
 
 
Intercalation and groove binding have very different effects on DNA structure. Whereas 
groove binders such as netropsin and distamycin only result in slight changes in structure, 
with DNA remaining basically unperturbed; substantial changes such as lengthening, 
stiffening and unwinding of DNA structure result from intercalation, producing definite 
effects on hydrodynamic properties.  This allows intercalators and groove binders to be 
experimentally differentiated.
36,37
 For example, viscosity measurements and Scanning Probe 
Microscopes (SPMs) provide a means of determining DNA binding modes, as they allow the 
length of plasmid DNA in both the presence and absence of DNA binding agents to be 
directly measured.
10
  Since the orientation of the ligand and its closeness to DNA bases can 
be investigated through dichroism and fluorescence energy transfer, these measurements can 
also possibly differentiate between groove binding and intercalation.
37
 The inhibition of 
polymerase activity by intercalators is often observed as the duplex is stabilized and therefore 
harder to unwind. Enzymes are also unable to bind to the disrupted regions of DNA, which in 
turn results in the inhibition of replication, transcription, or endonuclease activity. Many 




involved in twisting and untwisting (super coiling) of DNA during transcription and 
replication (Figure 1.15) - intercalate into alternating purine-pyrimidine sequences.17 
                                                                                                              
 
Figure 1.15: Amsacrine structure 
 
 
1.4.3.1 Organic intercalators                                                                                             
A number of studies have indicated that the minimal requirement for intercalative binding is a 
fused two-ring system.  Through NMR experiments, Sartorius, et al.
38 
have shown that there 
is no evidence for intercalation of isolated benzene rings and also that two condensed rings 
can only interact with DNA if assisted by positive charges in the side chains.  
Such ligands can intercalate without the assistance of side chains when they are three ring 
systems. In addition, Sartorius proved that the strength of intercalation is not influenced by 
the presence of hetero elements within the π-system. These effects are illustrated by the 
observation made on the quinolinium derivatives shown in (Figure 1.16). It was shown to 
bind in the minor groove of an oligonucleotide when the substituent R1 is attached.
39
 
However the corresponding acridinium analogue with R2 attached was shown to be an 
intercalator.
40





Figute 1.16: Quinolinim derivatives structure, with different R groups  
 
The activity relationship noticed between high DNA binding affinity and biological efficacy 
has resulted in compounds with more than one DNA intercalating group or cationic side 
chain to obtain higher affinity binding complexes.  Daunomycin is a characteristic example of 
such an organic intercalator. In cancer chemotherapy daunomycin is mainly used as an 
antibiotic for acute leukaemia
41
 (Figure 1.17).           
                                                                                                           
 





The lack of activity against resistant cancer cells is one of the most important problems 
connected with the main clinical anticancer drugs. In an attempt to overcome this problem, 
two of these drug molecules have been bound together.
42,43
 It was found from the original 
crystal structures of daunomycin binding to CGTACG
 41 
  that the drug binds to DNA in a 2:1 
ratio.  The drug is intercalated at either end of the nucleotide with the amine moieties 
pointing towards one another.  This arrangement brings the reactive NH2 substituent of each 
drug molecule closer than 7 Å. In an attempt to produce more powerful chemotherapeutics 
from this information a bisanthracycline molecule with the potential to bis-intercalate into 
DNA was designed.
42
 The connector had to be of suitable length and without steric hindrance 
so as to fit into the minor groove. To do this a para-xylene connector was used and the 




Figure 1.18: Chemical structure of WP631
44 
 
Generally, the binding affinity of bis-intercalators compared to the monomer should increase. 




of the two free energies of mono-intercalator binding, the binding constant of a bisintercalator 
ought to be nearly the square of those of the monomer.
42, 45
                         
The X-ray crystal structures of the WP631-DNA complex confirmed that the drug binds to 
DNA almost exactly as planned
 43
; with the planar aromatic groups intercalating inside the 
helix and the linker lying along the minor groove. The binding affinity of WP631 is also 
considerably improved, as shown by Chaires et al.
42
 The site size of bisintercalators is much 
bigger than their monointercalator counterpart, which should lead to improved selectively. 
Since daunomycin binding site fills three base pairs, the newer molecule should occupy twice 
as many base pairs. The greater site size should also impart a binding specificity similar to 
enzymes
42
. Experimentally, it was found that favoured binding sites usually contained the 
general sequence (G/C)(G/C)(A/T)(A/T)(G/C)(G/C). This molecule appears to address 
specific forms of multidrug resistance as initial biological studies in cultured cell lines 
revealed that it was more active than the original compound.        
                                                                           
 
1.4.3.2 Metallo-intercalators                                                                                
The study of transition metal complexes that reversibly bind to DNA is a growing research 
area. Complexes that bind to DNA through intercalation have become known as metallo-
intercalators (Figure 1.19, taken from reference 47). This growth of interest is due to the 
useful properties of transition metal complexes, which possess rich photophysical and 
electrochemical properties, allowing for extensive possible applications from luminescent 
labels to DNA foot-printing agents and electrochemical probes.
46
 The large choice of metal 
ions and ligands offers the possibility of tuning DNA binding and recognition properties. An 
important factor for stability in cellular conditions is that the interacting complexes need to be 
kinetically inert. Therefore the complexes that are most used are d
6
 octahedral and d
8
 square-









1.5 Mono- and bimetallic complexes 
1.5.1 Monometallic Complexes                           
From the early 1970s onwards, many examples of monometallic complexes that bind to DNA 





 that square planar complexes of platinum with 2,2':6'2,2'' terpyridine (tpy) or 
2,2'dipyridine could bind to DNA via intercalation, whereas the non-planar [Cu(dipy)2]
2+
 
(dipy = 2,2'-dipyridyl) behaves differently and binds via the minor groove, a fact that was 
later confirmed by X-ray studies.
51 
 
                                                                                            
• Tris(phenanthroline) Complexes      
In the early 1980s Barton et al. began to investigate octahedral metal complexes as DNA 









tris(phenanthroline) complexes of Zn(II) reversibly unwind the DNA duplex and partially 
insert between the base pairs. This suggestion was based on the different behaviour of closed 
circular DNA in the presence and absence of the metal complex during electrophoresis. From 
steric arguments, it was proposed that the Δ enantiomer preferentially bound to right handed 
DNA. 
1
H NMR studies on Δ- and Λ-[Ni(phen)3]
2+
, Δ- and Λ-[Cr(phen)3]
3+
 bound to 
oligonucleotides  described different behaviours depending on the isomer, with Λ-isomers 
preferring surface binding and the Δ-isomers apparently intercalating
54
 (Figure 1.20).     




Figure 1.20: Structure of different enantiomers of a [M(phen)3]
n+
, where M = central metal and n = 
represents the charge on the metal complex 
 
 
As a result of the kinetically inert characteristics of low spin d
6
 systems and also because of 
their metal to ligand charge transfer (MLCT) band in the visible region, ruthenium systems 
were later investigated and [Ru(phen)3]
2+
 gave similar evidence for stereospecific binding to 
DNA.
55
 Although it was later established by Chaires that these ligands could not intercalate 
as the phen ligand is not extended enough to insert between base pairs.
56
          






                                                                                                           
• Dipyridophenazine Complexes        
One important feature of metallo-intercalators is that they have rich photochemistry and 
photophysical properties, which can be influenced by their interaction with DNA.  This is 
illustrated by the molecular light switch intercalators first reported by Barton et al.
57
.  They 
understood that an increase in the surface of an extended ligand is important in creating a true 





 with DNA have been widely studied
57,58 
(Figure 1.21).
       
          
                                                                                                             
 
 







1.5.1.1 The molecular light switch effect 
Complexes such as  [Ru(bpy)2dppz]
2+
 (Figure 1.22, taken from reference 57) not only 




) but also display a photophysical 
phenomenon known as the ‘light switch effect’.
57






Figure 1.22: A) Metallo-intercalator [Ru(bpy)2(dppz)]
2+
, B) emission spectra of [Ru(bpy)2(dppz)]
2
 in 





The ability of a chemical substance to change emission colour as a result of change in solvent 
polarity is known as solvatochromic luminescence.  A molecular light switch deviates from 
this in the sense that upon moving from one environment into another a transition from no 
luminescence to intense luminescence is seen. In one environment the complex is basically 
“switched off” (with little to no luminescence), and then “switched on” in the other, thus the 
often made comparison with switching on a light. This feature is useful because it can be 
used to detect changes in micro-environment.
59
 The emission of the [Ru(bpy)2dppz]
2+
 
complex in aqueous condition is off because the excited state of the phenazine nitrogen atoms 
are quenched through the hydrogen bonding of water molecules
60
 but the luminescence is 
activated when interacting with DNA as the dppz is shielded from water. The light switch 
effect was first reported by Barton et al. and is shown in (Figure 1.22). 
                                                                                                                                
The characterisation of MLCT luminescence was reported by Sauvage et al. and they 
assumed that the light induced charge transfer (CT) is directed from the ruthenium atom to a 




MLCT excited state then decays rapidly 
via intersystem crossing (ISC) to a 
3
MLCT excited state primarily localised on the phenazine 





                                                  
  
Figure 1.23: Jablonski diagram illustrating excited states involved in the DNA light switch effect. 
                                                                        
                                                
From steady state emission spectra it was established that distinct discrimination in this effect 
could be observed between A-,B- and Z-DNA.
57
 In spite of the high affinity of these 






), there has been much discussion over the binding 
orientation of [Ru(phen)2(dppz)]
2+
. Photophysical studies show that both enantiomers of 
[Ru(phen)2(dppz)]
2+ 
exhibit bi-exponential decay of luminescence lifetime when bound to 
DNA.
62
 It has been suggested that in one mode the dppz ligand intercalates from the major 
groove, with the metal-dppz axis perpendicular to the base pair, while in the other mode the 
dppz ligand is side-on, with the metal-dppz axis situated along the long axis of the base pair 
(Figure 1.24). In this binding mode, one of the nitrogen atoms in phenazine is still reachable 
by water as it points out into the major groove, resulting in quenching of the excited state, 
although much more slowly than if it was free in solution. However, both of the nitrogen 
atoms in the perpendicular mode are completely intercalated inside the base pair stack, 
rendering them inaccessible to external solvents, which results in a significantly improved 









In 1998, the competition binding interaction of [Ru(phen)2(dppz)]
2+
 with a known major 
groove intercalator (Δ-α-[Rh[(R,R)-Me2trien]phi]
3+
) and a minor (distamycin) groove binding 
agents was investigated by Holmlin et al.
 63
  It was found that [Ru(phen)2(dppz)]
2+
 was 
displaced upon titration of the rhodium complex, while addition of the minor groove binder 
distamycin produces an increase in ruthenium emission, consistent with the double helix 
being able to accommodate major and minor groove binders at the same time. Distamycin has 
no effect on the emission of [Ru(phen)2(dppz)]
2+
 emission bound to poly d(GC). These 
photophysical results provide support for intercalation through major groove side of the 
duplex DNA. Later crystallographic work has suggested that this hypothesis is incorrect – see 
later.  
The binding mode of [Ru(phen)2(dppz)]
2+
 with DNA have investigated by Biver et al.
64
 using 
stop-flow and spectrophotometric methods and they identified a second non-intercalative 
binding mode in their studies. They supposed that the phen moieties reside in the grooves 




in partial unwinding of the helix and when sufficient unwinding has been realised, the 
[Ru(phen)2(dppz)]
2+
 inserts between base pairs  through a more typical intercalation mode. 
 
In 2012, Niyazi et al.
65 
described the crystal structures of the light switch ruthenium complex 
[Ru(phen)2(dppz)]
2+ 
bound to two oligonucleotide duplexes (Figure 1.25, taken from 





Figure 1.25: Crystal structures of ruthenium cation Λ-[Ru(phen)2(dppz)]
2+
 and oligonucleotides 
d(CCGGTACCGG)2 duplex (left) and d(CCGGATCCGG)2 duplex (right), Ru2, space-filling in 





This study reported that the ruthenium complex [Ru(phen)2(dppz)]
2+ 
binds to an 
oligonucleotide by two distinct modes of intercalation; symmetrical and angled intercalation, 
and in each case intercalation is through the minor groove of B-DNA. Semi-intercalation of 
one phen ligand is also seen in the symmetrical mode of dppz intercalation seen at the central 
TA/TA step of the oligonucleotide duplex (Figure 1.26, taken from reference 65). The 
structure also shows changes in DNA conformation at the intercalation point that are similar 
to those found in the crystal structure of certain classical DNA intercalators such as 









Figure 1.26:  Geometry of intercalation modes of Λ-[Ru(phen)2(dppz)]
2+
 complex with 
oligonucleotides
65
. (A) Angled intercalation; (B) Semi-intercalation of one phenanthroline ligand and 
(C) Symmetrical intercalation 
 
 
Metal complexes bearing more bulky intercalating ligands serve as probes for DNA 
mismatches. In the developing of diagnostics and therapeutics for cancer DNA mismatches 
represent a unique target, because lacks in DNA mismatch repair are implicated in cancers, 
























reported the crystal structure of Δ-[Ru(bpy)2(dppz)]
2+
 bound to both mismatched and well-
matched sites in the oligonucleotide 5̕-(dCGGAAATTACCG)2-3̕ (Figure 1.27, taken from 
reference 66). The results also reveal that the binding of Δ-[Ru(bpy)2(dppz)]
2+ 
complex to 
mismatches DNA occurs via metalloinsertion, while additional ruthenium complexes 




Figure 1.27: Two independent views of (A) metalloinsertion at the mismatched sites and (B) 








In the case of metalloinsertion, through the dppz ligand, the complex inserts tightly from the 
minor groove and completely ejects the mispaired adenosines. Again intercalation at well-
matched base pairs occurs from the minor groove side 
67
 (Figure 1.28, taken from reference 























Figure 1.28: Structure of Δ- [Ru(bpy)2dppz]
2+
 and three DNA binding modes highlighted for 




• Benzo-dipyridophenazine Complexes 
In order to explore how the structure and nature of an extended dppz ligand with an extra 
aromatic ring affected the luminescence properties in the absence and presence of DNA of 
such systems, a benzo-dipyridophenazine (dppn) complex in the form of [Ru(phen)2(dppn)]
2+
 
was first reported by Barton et al. (Figure 1.29)
58
 Compared to the parent complex 
[Ru(phen)2(dppz)]
2+
, the dppn complex did not show a light switch effect. Later research 
revealed that the rhenium (I) complex of dppn has very different excited properties and 







 DNA duplex 










(dppz) systems, which display an MLCT-based lowest excited state, transient 
absorption studies on Ru
II
(dppn) complexes revealed that the lowest excited state of these 
complexes is a 
3
π-π* state centred on the dppn ligand, which was confirmed by DFT 







complexes (tpm = tris(1-pyrazolyl)methane) reported by Foxon et al.
69
 This metallo-
intercalator system may find potential applications in therapeutic systems such as 
photodynamic therapy (PDT). In this application, targeted tissue is exposed to specific light 
radiation that induces the production of reactive chemical species, causing adverse effects in 
and around the surrounding tissue.  
 
In 2014, Yin et al.
70 
prepared a series of Ru(II)-based transition metal complexes derived 
from this π-expansive ligand (Figure 1.30) and showed that the low-energy and long-lived 
3
IL excited states photocleaved DNA with blue, green, red, and near-IR light. The aim of 
their investigation was to discover whether 
3
IL excited states with microsecond lifetimes are 
generally effective for photodynamic applications, and if these long-lived states are better 
than their 
3
MLCT counterparts as in vitro PDT agents. They showed that related Ru(II) 
complexes having lowest-lying 
3
MLCT with much shorter lifetimes did not produce DNA 
photodamage or in vitro PDT effects with red or near-IR light. They concluded that 
complexes that utilise photosensitizing 
3








Figure 1.30: Chemical structure of [Ru(LL)2(dppn)]
2+
 (where LL = 4,4′-dimethyl-2,2′-bipyridine 




• Tetraazophenanthrene ligand and its complex      
The ability of ruthenium-dppz complexes to photo-oxidize nucleic acid
71,72
 within living cells 
is one of the inspirations for this study. Incorporating electron deficient ligands like 1,4,5,8-
tetraazophenanthrene(TAP) into octahedral ruthenium complexes greatly affects its excited 
states causing direct oxidation of guanine moieties; it also leads to covalent adduct formation 
with nucleic acids.
73
 Since the [Ru(TAP)2(dppz)]
2+
 complex  is structurally close  to 
[Ru(phen)2(dppz)]
2+
, it also binds to a wide range of double-stranded DNA sequences.  In the 
presence of guanine, the excited state of [Ru(TAP)2(dppz)]
2+
is quenched and the oxidation of 
guanine appears to proceeds by proton coupled electron transfer  as suggested by picosecond 
transient absorption experiments.
74
     










X-ray structure of the [Ru(TAP)2(dppz)]
2+
 complex   
The crystal structure of this complex bound to DNA showed that the ruthenium polypyridyl 
complex sits in duplex DNA with one ligand acting as a wedge in the minor groove, resulting 
in kinking of the double helix. In the presence of barium ions, the Λ-[Ru(TAP)2(dppz)]
2+
  
cation crystallizes with the oligonucleotide d(TCGGCGCCGA) in a 1:1 ratio. In each 
complex the dipyridophenazine ligand binds to one duplex by intercalation and one of the 
orthogonal TAP ligands binds into a second symmetrically equivalent duplex through semi-
intercalation. Non-covalent cross linking and marked kinking of DNA is the result of this 
binding (Figure 1.32, taken from reference 75).
75





Figure 1.32: Structure of the complex cation [Ru(TAP)2(dppz)]
2+ 
with oligonucleotide 
d(TCGGCGCCGA).(A) Shows the ruthenium complex with two symmetry connected strands and  




Figure 1.33: Binding modes of the ruthenium complex [Ru(TAP)2(dppz)]
2+ 
with oligonucleotide. (A) 
Barium ions and the intercalated ruthenium complex cation showed by one d(TCGGCGGA)2 (dppz, 
pink; TAP1, purple: TAP2, white) (B) Semi-intercalated of TAP1 between G3-G4 step.
75
   
 
                                                                          
(A)  (B)  




● Different binding modes of the TAP and dppz ligands             
Most noticeably, the two chemically identical TAP ligands (differentiated as TAP1 and 
TAP2) possess very different roles within the structure caused by the intercalation geometry 
of [Ru(TAP)2(dppz)]
2+
 which also leads to enantiomeric specificity (Figure 1.33). At the G3-
G4 step the TAP1 ligand semi-intercalates from the minor groove, only interacting with the 
guanine component of the base pair but not the corresponding C7-C8. TAP2 lies between the 
minor grooves of two duplexes and remains inert in terms of the overall supramolecular 
structure. Together, the TAP1 semi-intercalation inside the G3-G4 step and the flipped out 
T1-A10 base pair, link symmetry equivalent duplexes. TAP1 also makes a series of close 
contacts with the six-membered purine rings of G3 and G4.
76
 Furthermore, semi-intercalation 
makes a binding site for a barium ion fairly different from that seen in the absence of Λ- 
[Ru(TAP)2(dppz)]
2+
, with straight coordination to the N7 positions of G3 and O6 and N7 of 
G4 (Figure 1.34, taken from reference 75).  
 
The structure confirms that the dppz ligand of this complex does intercalate into the DNA 
duplex as suggested by spectroscopic and hydrodynamic data.
58, 77,61-63,78,79 
                                                                                                                                    
As with the TAP semi-intercalation, and like the previously described structures, intercalation 
of the dppz ligand takes place from the minor groove. The interaction between the pyrazine 
ring of the dppz ligand and the six-membered purine rings of G9 and A10 is the principle 
stacking interaction, so that the distance of the ruthenium atom is almost 6.5Å from the 
helical axis of the duplex. The dppz does not make contact with any of the surrounding water 






Figure 1.34: The hydration and coordination of barium ion to N7 of guanine G3 and O6 of guanine 




1.5.2 Bimetallic Complexes                                                                                                 
As outlined in a previous section, polyfunctional intercalating agents can improve the affinity 
and selectivity of DNA.
80
 The preparation of covalently linked bifunctional compounds 
designed to improve DNA interaction has been investigated by some research groups. For 





 into bimetallic systems
81,82
 (Figure 1.35). They reported that 
the length of the linker chain (n) is a crucial factor in determining the binding efficiency and 
to show a DNA stacking interaction at high binding concentrations. 





Figure 1.35: Structure of [L2Ru(II)(Me-bpy)-(CH2)n-(bypMe)Ru(II)L2], (where L = 2,2’-bpy or 1,10-
phen and n=5,7 or 10) 
 
 
Nordén et al. have also described the interaction of a dimeric complex with two linked dppz 
units (Figure 1.36).
83




) the four compounds (ΔΔ-bpy/Λ Λ-
bpy and ΔΔ-phen/Λ Λ- phen) were found to bind to DNA, but through a more complex form 
of interaction. Initially both ΔΔ and ΛΛ-bpy isomers, in addition to ΛΛ-phen, present a 
binding geometry in which the (dppz -11, 11´- dppz) ligand overlaps the sugar-phosphate 
backbone placing the RuL2 moiety in each groove, while different behaviour was displayed 
by the ΔΔ-phen complex. Further studies done on the interaction of the ΔΔ-phen isomer with 
CT-DNA revealed that this complex switches from groove binding to intercalation by 
threading one of the [Ru(phen)2]
2+
 moieties through the DNA duplex, leaving one metal  
centre in each groove.
84
             










The crystal structure of one of the phen versions of the above binuclear ruthenium complex 
(Δ,Δ[µ-(11,11’-bidppz)(1,10-phenanthroline)4Ru2]
4+
) bound to the oligonucleotide 
d(CGTACG) was reported by Boer et al.
85
 (Figure 1.37, taken from reference 85). It shows 
that an AT base pair is extruded when one dppz ligand of the binuclear ruthenium complex 
inserts into the DNA stack, while the second dppz moiety recruits an adjacent DNA 
molecule, and by bridging their major grooves the complex cross-links two neighbouring 





Figure 1.37: Structure of the ruthenium complex and the oligonucleotide (a) shows a single molecule 











In 2015, Almaqwashi et al. utilise the (Δ,Δ[µ-(11,11’-bidppz)(1,10-phenanthroline)4Ru2]
4+
) 
binuclear ruthenium complex to measure its binding properties (Figure 1.36). They used 
optical tweezers to measure elongation of the DNA at a range of constant stretching forces 
and characterized the kinetics of intercalation as well as the extent of intercalation at 
equilibrium. This study revealed that the zero force intercalation of the binuclear ruthenium 
complex is 25-fold stronger than the analogous mononuclear complex. Moreover, a 
mechanism that requires DNA elongation for association, relaxation and an additional 
elongation for dissociation from the equilibrium state was revealed by the force dependent 
kinetics analysis.
86
   
 
The phenomenon of DNA threading has also been studied in dppz tethered units with a 
longer and more flexible linker. The three enantiomers of [µ-c4 (cpdppz)2-(phen)4Ru2]
4+
  have 
been synthesised and their binding to DNA characterized by Nordén et al. (Figure 1.38).
87,88
 
Linear dichroism (LD) measurement, luminescence spectroscopy and other studies confirmed 
intercalation of all the complexes between base pair of DNA, with the intercalating ligands 
separated by two base pairs. Due to the binding mode this complex exhibits, it is known as a 
DNA staple (Figure 1.39).   










Figure 1.39: Schematic DNA interaction modes of Nordén’s dimer: A) External binding, B) Groove 
binding, C) Mono-intercalation, D) Bis-intercalation. 
 
Recent work focused on the influence of the DNA binding properties of [µ-c4 (cpdppz)2-
(phen)4Ru2]
4+
 system (Figure 1.38) for therapeutic use. To quantify ligand binding, a study 




process; the first step shows fast bimolecular intercalation of the first dppz moiety followed 
by almost 10-fold slower intercalation of the second dppz moiety and the second step is the 
rate that allows the flexible linker to pass through the DNA duplex. Based on the force 
dependent binding rates and ligand-induced DNA elongation measurements, at zero force the 
complete binding route involves fast association, slow dissociation and very high affinity.
89
 
Metcalfe et al. have developed a facile route to the synthesis of non-threading bimetallic 
Re(I) complexes containing two dppz  intercalating ligands.
90
 Studies showed that the 
propane tether is not long enough to allow binding of both [(CO)3Re(dppz)]
+
 units (Figure 
1.40) with DNA, so the second Re(I) centre interacts with another duplex via interstrand 
binding.                                                   
 
 
Figure 1.40: Structures of Re(I)dppz complexes 
 
Studies on tpm-Ru(II)-dppz binding systems connected together by 4,4´-dipyridyl-1,5-
pentane (dpp) (Figure 1.41) with DNA were described.
91
 Similar affinities for both 




) were shown using luminescence and ITC titrations. 
However, compared with other simple monometallic systems these interactions are 
significantly weaker. In the monomer complex the bulky ancillary ligand produced a loss in 
the selectivity for GC sequences seen for other mononuclear tpm-Ru(II)-dppz system.
92
 
However, the binding constant of the monomeric analogues was expected to be greatly 




explained through a consideration of the length and rigidity of the connecter employed in the 
complex.                          
 
 
Figure 1.41: Structure of mono and bimetallic complexes of tpm-Ru(II)-dppz 
 
 





 established an order of magnitude increase in the binding affinity compared 
to the monomeric analogue (containing pyridine instead of the dpp linker); along with a much 
enhanced light switch effect, which is relatively weak in the Re
I
 complex. In addition to that, 
the Ru-Re system also causes direct cleavage of DNA and as such is the first example of a 




















1.6 Project Aims 
The aim of this project is to prepare a series of bimetallic complexes of tpm-Ru(II)-dppz 
linked with new organic tethers designed to enhance the binding affinity, the DNA sequence 
recognition property, and the photophysical properties of these systems. This will be 
accomplished by either changing the position of pyridine nitrogen atoms in the organic linker, 
or by using different substituents within the organic linker. Furthermore, in these complexes 
the linker contains hydrogen bonding ammine groups capable of interacting within the 
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In recent times a large amount of research has concerned ruthenium polypyridyl complexes 
system as DNA binding agents, particularly developing systems that show a ‘light switch’ 
effect or form photo-adducts. The use of complexes with extended aromatic ligands has been 
a particular focus as this improves non-covalent binding through intercalation.
1,2 
More 
recently, in an attempt to increase the binding affinity and DNA sequence recognition 
properties of such complexes bimetallic systems have been investigated by Nordén and 
Kelly. However, the multi-step syntheses, starting from coordinatively saturated, classically 
resolved chiral metal complexes, are not trivial. In this chapter  we  describe  the  synthesis  
and  characterisation  of  a  number of  bimetallic  complexes  using achiral 
[Ru(tpm)(L)(dppz)]
n+
 complexes (tpm = tris(1-pyrazolyl)methane, L = chloride or N-donor 
ligand, dppz = dipyrido[3,2-a:2´,3´-c]phenazine), which contain an easily modulated 
coordination site (2−4) (Figure2.1).
3-5
  To ascertain how the nature of the linker affects 








 [3] and [{Ru(tpm)(dppz)}2(μ-
L2)]
4+









2.2.1 Linker syntheses 
N,N’-bis(4-pyridylmethyl)-1,6-hexanediamine (L1) was synthesized by refluxing a 
solution of 4-pyridinecarboxaldehyde and 1,6-hexanediamine in ethanol. Addition of NaBH4 
in small portions and extracting the aqueous solution with CH2Cl2, followed by evaporation 
yielded a cream colored solid precipitate.  
 
 
Figure 2.2: Synthesis of L1  
 
 
N,N'-bis(4-pyridylmethyl)-1,4-benzenedimethyleneamine (L2) was prepared by stirring 
the mixture of benzene-1,4-dicarboxaldehyde and 4-(aminomethyl)pyridine in CH2Cl2(100 
ml) with anhydrous MgSO4 (at room temperature for 24 h). Addition of NaBH4 in small 
portions and extracting the aqueous solution with CH2Cl2 yielded a golden coloured viscous 
oil product on evaporation of solvent. 
 
 







2.2.2 Synthesis of complexes 
2.2.2.1 Monometallic complexes 
[Ru(tpm)(dppz)(µ-L1)](PF6)2 [1] and [Ru(tpm)(dppz)(µ-L2)](PF6)2 [2].  
Complexes [1] and [2] were prepared by refluxing [Ru(tpm)(dppz)Cl]
+
 and AgNO3 in 
ethanol:water followed by the addition of the L1 or L2 ligand, respectively. AgNO3 was 
added to remove the axial chloride ligand, which precipitated as AgCl and was then removed 
by filtering through celite. After reflux, the desired complex was precipitated as a PF6ˉ salt by 
reducing the solvent volume and adding excess NH4PF6 (Figure 2.4). Both ruthenium 
complexes were further purified on alumina using column chromatography (acetonitrile: 
toluene). 
 





2.2.2.2 Bimetallic complexes  
[{Ru(tpm)(dppz)}2(µ-L1)](PF6)4 [3],[{Ru(tpm)(dppz)}2(µ-L2)](PF6)4 [4]. Both complexes 
[3] and [4] were synthesized in an identical procedure starting by refluxing 
[Ru(tpm)(dppz)Cl]
+
 in ethanol:water. Again, AgNO3 was added to remove the chlorido 
ligand. The filtered solution was then added to [(tpm)Ru(dppz)(L1)](PF6)2 or 
[(tpm)Ru(dppz)(L2)](PF6)2 in acetone and was refluxed for 3 days. The solution was then 
concentrated and purification was achieved via ion-exchange chromatography on Sephadex 
CM-25 resin eluting with water acetone mixtures (5:3) with increasing concentrations of 
NaCl. The fractions containing the product were concentrated and the product was 
precipitated by addition of NH4PF6. 
 






2.3.2 Mass spectrometry data 
Electrospray data recorded on an ES-TOF spectrometer for the complexes [1], [2], [3] and [4] 
are summarised in the table below. All of the complexes showed fragments in their mass 
spectrum that correspond to their proposed structures, commonly peaks were found that 











 (1) [Ru(tpm)(dppz)(µ-L1)][PF6]2 1041.2716 100 [Ru(tpm)(dppz)(µ-L1)]
+
[PF6] 
 (2) [Ru(tpm)(dppz)(µ-L2)][PF6]2 1061.2435 100 [Ru(tpm)(dppz)(µ-L2)]
+
[PF6] 
(3) [{(tpm)Ru(dppz)}2(µ-L1)][(PF6)4] 892.1607 100 [{(tpm)Ru(dppz)}2(µ-L1)]
2+
[(PF6)2] 
(4) [{(tpm)Ru(dppz)}2(µ-L2)][(PF6)4] 901.76 100 [{(tpm)Ru(dppz)}2(µ-L2)]
2+
[(PF6)2] 




2.3.3 Photophysical studies 
UV-visible absorption spectra of [1-4] were recorded at room temperature in water (as 
chloride salts) and acetonitrile (as hexafluorophosphate salts). The UV-visible absorption 







Figure 2.6: UV-Visible absorption spectra for the complexes [1], [2], [3] and [4] as PF6 salts in 
acetonitrile at room temperature 
 
 
These UV−Visible spectra are dominated by high-energy bands between 270−300 nm which 
correspond to π→π* transitions of the aromatic nitrogen donor ligands. The corresponding 
spectrum of free dppz in acetonitrile exhibits a moderately intense band in the near-UV with 
two principle maxima at  = 358 and 376 nm, which are characteristic of π→π*(dppz) 
transitions.
8
 Consequently, the moderately intense bands in the near-UV regions for 
complexes 1 (351nm), 2 (350 nm), 3 (355 and 368 nm) and 4 (352 and 395 nm) are assigned 
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Table 2.2: UV-Visible data for the complexes [1], [2], [3] and [4] as PF6 salts recorded in acetonitrile. 
 
The MLCT Ru(dπ)→dppz(π*) 
1
MLCT bands for 1−4 all appear in the region of the spectrum 
typical for ruthenium(II) complexes with coordinated polyimine ligands. Excitation into the 
MLCT band of complexes 1−4 in acetonitrile solutions results in characteristic broad and 
unstructured emission originating from the Ru(dπ)→dppz(π*) 
3





















































Table 2.3: Emission data for the complexes [1], [2], [3] and [4], where λex = excitation wavelength, 
λem = emission wavelength. 
 
The corresponding absorbances for these complexes as chloride salts in water are also 




Figure 2.7: UV-Visible absorption spectra for the complexes [1], [2], [3] and [4] as Chloride salts in 
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Table 2.4: UV-Visible data for the complexes [1], [2], [3] and [4] as chloride salts recorded in 5mM 








2.3.4 DNA Binding Studies 
The well-defined spectroscopic characteristics of a metal complex often change when they 
interact with DNA. This is because the complex is subjected to a change in local 
microenvironment from being completely solvated in aqueous solution to being in the 
hydrophobic environment of a DNA helix; either within the grooves or between base stacks. 
This change in local microenvironment can be observed in the UV-Visible spectrum of the 
complex. During the binding process, the central metal ion and the aromatic ligands come 
into close proximity to the poly-anionic backbone of the DNA and the hydrophobic interior 
of the DNA grooves. This causes alterations in the metal centred MLCT band and the ligand 
centred π → π* bands of the UV-Visible spectrum of the complexes 
9,10,11
. These shifts are 
often to a longer wavelength (bathochromic shift) and are frequently accompanied by 
absorption decreases (hypochromic shift) indicating that, upon binding to DNA, the energy of 
the transition has been altered by stabilisation or destabilisation of the HOMO/LUMO 
orbitals involved in the transitions.
11
 
Excited state luminescence emission spectra of the complex are also often sensitive to local 
environment.  Water molecules can act as excited states quenchers, specifically where they 
can form hydrogen bonds to nitrogen donor sites on the complexes.  Upon binding to DNA 
the ligand based nitrogen donor sites are protected from the aqueous solvent by the 
hydrophobic interior of the grooves and the base stack. As a result the excited state of the 
complex can change significantly, resulting in large changes in emission.
3
  
In this study all of the metal complexes exhibit well-defined UV-visible spectra in both 
lipophilic and aqueous environments. Therefore, the change in the absorption and emission 
properties of the metal complexes can be used as a spectroscopic tool to study the binding 
interactions of the metal complexes with DNA.  
The degree of shift in any given band from the titration of known concentration of drug with 
DNA in UV-Visible spectrum or the luminescence spectrum is proportional to the fraction of 
drug bound to the DNA. For hypochromic shifts in the UV-Visible spectrum, the fraction 
bound of complex (χ) to DNA is estimated from the equation: 
 









Where Af is the absorption of the free unbound drug, Ab is the absorption of the fully bound 
drug x and Aobs is the absorption at a given point. Similarly for luminescence titrations where 
the emission intensity of the drugs increases upon binding to DNA the fraction bound is 
given by: 
 
𝛘 =  
𝐈𝐨𝐛𝐬− 𝐈𝐟
𝐈𝐛− 𝐈𝐟
                                                 Equation 2.2 
 
Where Iobs , If and Ib are the emission intensities of the observed, free unbound and fully 
bound complex respectively. 
If χ is plotted against the ratio of the DNA concentration to drug concentration 









The concentration of bound drug (Cb) can be easily calculated at any given time from 
knowing the initial concentration of complex (Ci) and the fraction bound (χ).  
 
Cb =  χ . Ci 
Equation 2.3 
 
Cf is the concentration of free drug, then 
  
Ci = Cf + Cb 
Equation 2.4 
 
Rearranging equation 2.4 to make Cf the subject gives the following equation.   
 
 




Finding the concentrations of free unbound and bound drug at any given time allows the 
binding ratio (r), which is described as the ratio of bound complex to total concentration of 
DNA to be determined. 
 










By plotting r Cf⁄  vs. r from the Scatchard equation shown below, the intrinsic equilibrium 
binding constant (Ki) and the number of DNA binding sites occupied by the bound 




= Ki(n − r)  
Equation 2.7 
 
The Scatchard model was developed for the binding of small ligands to non-interacting 
isolated binding sites on proteins;
12
 although it works well for simple systems with 1:1 
binding solutions, in more complicated systems, where data is no longer linear, the plot 𝒓 𝑪𝒇⁄  
vs. 𝒓 quickly begins to show weaknesses. To fit the data more accurately a more complicated 
plot can be used (Equation 2.8). This is done so using the McGhee Von Hippel model
13
 
which makes a number of assumptions; essentially it takes into account overlapping binding 





= 𝐾. (1 − 𝑛𝑟). [
(1 − 𝑛𝑟)






As the binding reaches saturation, the numbers of free binding sites remaining require a 
significant increase in effective concentration of complex to bind.
14
 This has a significant 
effect on the data and artificially increases the observed binding constant. The model is fitted 








  2.3.5 UV-Visible titrations     
The interaction of [1]Cl2, [2]Cl2, [3]Cl4 and [4]Cl4 with CT-DNA in aqueous buffer (25 mM 
NaCl, 5 mM tris, pH 7.0) was investigated using UV–visible and emission spectroscopic 
titrations. Addition of CT-DNA to a solution of any of the complexes results in 
characteristically large hypochromicity in both MLCT and π→π* absorption bands due to the 
changes in the local microenvironments of the metal complexes. 
 
 
Figure 2.9: UV-Visible titration of 1.00 mM bp
-1
 CT-DNA into a solution of 15 μM 


























Figure 2.10: UV-Visible titration of 1.00 mM bp
-1
 CT-DNA into a solution of 15 μM 
[Ru(tpm)(dppz)(µ-L2)]Cl2 ([2]Cl2) in 5 mM tris buffer, 25 mM NaCl, pH 7.4 at 25 °C. 
 
Figure 2.11: UV-Visible titration of 1.00 mM bp
-1
 CT-DNA into a solution of 15 μM 







































Figure 2.12: UV-Visible titration of 1.00 mM bp
-1
 CT-DNA into a solution of 15 μM 
[{(tpm)Ru(dppz)}2(µ-L2)]Cl4 ([4]Cl4) in 5 mM tris buffer, 25 mM NaCl, pH 7.4 at 25 °C. 
 
 
The bands at ~277 nm and ~359 nm in all complexes show hypochromicity as CT-DNA is 
titrated into the complex solution. The hypochromicity has usually been ascribed to the 
interaction between the electronic states of the compound and those of the DNA bases.
15
 A 
bathochromic shift, characteristic of intercalation
16
 is seen at ~277 nm as the band moves 
towards ~292 nm. The red shift has been linked with the decrease in the energy gap between 






















































































To study further the interaction of complexes 1-4 with DNA and to explain the different 
photophysical responses of the molecules, emission titrations have also been carried out with 
the CT-DNA. 
 
2.3.6 Luminescence emission titrations 
Luminescence titrations for all the complexes were carried out using similar procedure to the 
UV-Vis titrations. All of the complexes display virtually no emission in tris buffer. Addition 
of CT-DNA into the complexes resulted in significant enhancements of the 
3
MLCT 
luminescence emission for each complex, indicating that all the complexes are behaving as 
DNA light switch systems.  
 
                                                
 
 
Figure 2.14: Luminescence titration of 151 μM bp
-1
 CT-DNA into a solution of 15 μM [1]Cl2 in 5 





























Figure 2.15: Luminescence titration of 151 μM bp
-1
 CT-DNA into a solution of 15 μM [2]Cl2 in 5 
mM tris buffer, 25 mM NaCl, pH 7.4 at 25 °C. λex = 430 nm. 
 
 
Figure 2.16: Luminescence titration of 1.0 mM bp
-1
 CT-DNA into a solution of 15 μM [3]Cl4 in 5 













































Figure 2.17: Luminescence titration of 151 μM bp
-1
 CT-DNA into a solution of 15 μM [4]Cl4 in 5 
mM tris buffer, 25 mM NaCl, pH 7.4 at 25 °C. λex = 460 nm. 
 
 
The binding curve for the interactions of these complexes with CT-DNA shows that 



























Figure 2.18: Binding curves obtained from the luminescence titrations of [1]Cl2, [2]Cl2 and  [4]Cl4  




Figure 2.19: Binding curves obtained from the luminescence titrations of [3]Cl4 binding to 1.00 mM 


















































Attempts to fit the binding data for the luminescence and absorption titrations to the Mcghee 
Von Hippel model were unsuccessful. It may be that these complexes bind to DNA very 
strongly preventing fits to the model or that in these conditions there is more than one binding 
mode.  For whatever reason, attempts to fit these titrations to the model produced unfeasibly 
large complex:DNA binding ratios. To explore this issue, luminescence titrations at high salt 
concentration (200 mM NaCl) were carried out and as a result of this increase in ion strength; 
fits to the Scatchard plots for the complexes became possible. In these conditions, the 
monometallic complex [1]Cl2 was found to have a very similar binding affinity compared to 
dinuclear complex [3]Cl4, indeed, within experimental error it is identical. 
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Figure 2.20: Scatchard plots for the complexes [1]Cl2  (right) and [3]Cl4 (left) obtained from the 
luminescence titration  of CT-DNA in 5 mM tris buffer, 200 mM NaCl, pH 7.4. Data fitted using 
McGhee Von Hippel binding model. 
 
 
In addition, as an alternative to McGhee Von Hippel binding model, using the absorption 
data at low NaCl concentration, the model first developed by Wolfe, et al. was used as well 
to estimate the binding constants 𝐾𝑏 for the interaction of these complexes with CT-DNA. 
This model uses the changes of absorption with increasing concentration of DNA and the 
following equation
18





















( ± 0.209)  





Where [DNA] is the concentration of DNA, 𝜀𝑎, 𝜀𝑓 and 𝜀𝑏 corresponds to the apparent 
absorption coefficient  
𝐴𝑜𝑏𝑠
[𝑐𝑜𝑚𝑝𝑙𝑒𝑥]⁄ , the extinction coefficient for the free complex and 
the extinction coefficient for the complex in the fully bound form, respectively.  
 
In plots of [𝐷𝑁𝐴]/ ( 𝜀𝑎 − 𝜀𝑓) versus [𝐷𝑁𝐴] (Figure 2.21 and 2.22), 𝐾𝑏 is given by the ratio 




Figure 2.21: Scatchard plots for the complex [2]Cl2 obtained from the absorption spectroscopy of 



























Figure 2.22: Scatchard plots for the complex [4]Cl4 obtained from the absorption spectroscopy of 






[1]Cl2 2× 𝟏𝟎𝟓 (±0.2) 
[2]Cl2 3× 𝟏𝟎𝟓 (±0.1) 
[3]Cl4 2× 𝟏𝟎𝟓 (±0.1) 
[4]Cl4 3× 𝟏𝟎𝟓 (±0.2) 
 
Table 2.4: Binding constants obtained by UV-Visible titrations of CT-DNA with complexes [1-4], Kb 
is Intrinsic binding constants.  
 





















Surprisingly the Kb value obtained using the simpler model and the UV-Visible titration data 
at 25 mM [NaCl] are an order of magnitude lower than those obtained from McGhee Von 
Hippel binding model for the luminescent studies on CT-DNA at 200 mM [NaCl]. This may 
be due to the different assumptions in the models or it may be that there are different binding 
modes when the dielectric of the solutions is changed. This is an issue that can be explored in 
more detail in the future.  
In either case however, the trend in the data is similar, indicating that there is very little (if 
any) enhancement of binding affinity of bimetallic complexes [3] and [4] with respect to 
analogous monometallic complexes [1] and [2]. This result is interpreted by a consideration 
of the rigidity of the linker employed in the complex. 
The observations of large hypochromicity in both MLCT and π → π* absorption bands and 
also the enhanced emission intensity upon addition of CT-DNA are all consistent with the 
interaction of a metallo-intercalator and DNA.
19-23 
However these observations do not 
provide definitive proof of an intercalative DNA binding modes for [1]Cl2, [2]Cl2, [3]Cl4 and 
[4]Cl4. One simple method for authoritatively distinguishing binding modes is the 




Viscosity measurements afford a direct and sensitive method to confirm if a compound is a 
true intercalator, as an increase in the length of a DNA sequence will occur when base pairs 
separate to accommodate an intercalating molecule. To check out the validity of viscosity 
measurements Hoechest 33258 (H33258) and ethidium bromide (EtBr) were used as a control 
compounds. Due to its groove binding mode, Hoechst 33258 does not induce any changes in 
viscosity upon interaction with DNA, while the known intercalator ethidium bromide does 
increase the relative viscosity of DNA.  
 
It was found that the relative specific viscosity of CT-DNA increased upon addition of [1]Cl2, 
[2]Cl2, [3]Cl4 or [4]Cl4. These measurements also reveal that the nature of the functional 
group has an effect on the viscosity changes caused by the complexes. It is also notable that, 
in both case, these monometallic complexes [1] and [2] appear to lengthen DNA more than 




full insertion of the complex between DNA base pairs, whilst in the case of the mononuclear 
complexes it is easier for the linker to sit within the minor groove, resulting in enhanced 
binding compared to their dinuclear analogues. The changes in DNA viscosity for complexes 
1 and 3 does confirm that they bind to DNA through intercalation, but suggest that for the 
dinuclear complex perhaps only one site is fully intercalating. However, as Figure 2.24 
shows the viscosity changes induced by 2 and 4 are considerably smaller than those induced 
by 1 and 3. This suggests that either these complexes are not intercalating or are more 
selective so that they only bind at a smaller number of sites to produce an overall lower bulk 
change in viscosity. 
 
 
Figure 2.23: plot of relative viscosity (η/η0)
1/3
 of CT-DNA versus R
-1
 (R = [DNA]/[Compound]) 
upon addition of  EtBr, H33258, [1]Cl2 and [3]Cl4. Experimental conditions: 5 mM Tris, 25 mM   


























Figure 2.24: plot of relative viscosity (η/η0)
1/3
 of CT-DNA versus R
-1
 (R = [DNA]/[Compound]) 
upon addition of  EtBr, H33258, [2]Cl2 and [4]Cl4. Experimental conditions: 5 mM Tris, 25 mM  
NaCl, pH 7.4 at 26°C. 
    
Four new polypyridyl ruthenium (II) complexes containing a linker group and their DNA 
binding properties have been established. The combination of viscometry, fluorescence 
and absorption spectroscopy data show that these complexes bind to DNA, most likely 
through intercalation. Complexes [1] and [3] seem to intercalate more strongly than 
complexes [2] and [4]. It seems the more rigid linker group may restrict full insertion of 
intercalative sites between the DNA base pairs. For the more flexible linker, the complex 
can sit more comfortably within the minor groove resulting in enhanced the binding 
compared. Whatever the reason, it is clear that the binding affinity of these complexes 
towards DNA is affected by the nature of the functional group in a linker.   
To further investigate the properties of these complexes with DNA, isothermal titration 
calorimetry (ITC) was used as this can provide a complete thermodynamic profile on the 
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In the previous chapter, four new ruthenium dppz complexes were reported. Binding studies 
show that the mononuclear complexes intercalate into CT-DNA with almost the same 
affinities as the related dinuclear complexes, probably due to the linkers of the dinuclear 
complexes restricting tight intercalation of the complex between DNA base pairs.  Given this 
observation, it is of interest to investigate how the nature and difference in positioning of the 
tether group affects the biological activity and DNA binding affinities of analogous systems.  
Previously in the Thomas group, work on achiral [Ru(tpm)(dppz)L]
2+
 cation systems  
containing monodentate ancillary pyridyl ligands (Figure 3.1) have shown that the nature and 
position of a single functional group can greatly modulate the DNA binding properties of the 
resultant complex
1
 and, in the case of the 4-aminopyridine complex, can even entirely 
“switch off” intercalative binding, due to the close contacts made by coordinated ancillary 











This chapter describes work aimed at synthesizing four ruthenium complexes bearing new 
linkers designed to interact with DNA and comparing their photophysical and 




3.3.1 Linker syntheses 
N,N’-bis(3-pyridylmethyl)-1,6-hexanediamine (L'1) was synthesized by refluxing a 
solution of 3-pyridinecarboxaldehyde and 1,6-hexanediamine in ethanol. Addition of NaBH4 




Figure 3.2: Synthesis of N,N’-bis(3-pyridylmethyl)-1,6-hexanediamine (L'1) 
 
 
N,N'-bis(3-pyridylmethyl)-1,4-benzenedimethyleneamine (L'2) was prepared by stirring a 
mixture of benzene-1,4-dicarboxaldehyde and 3-(aminomethyl)pyridine in CH2Cl2 (100 ml) 
with anhydrous MgSO4 (at room temperature for 24 h). Addition of NaBH4 and extracting the 
aqueous solution with CH2Cl2 yielded a golden coloured viscous oil product. 
 




3.3.2 Synthesis of complexes 
3.3.2.1 Monometallic complexes 
[Ru(tpm)(dppz)(µ-L'1)](PF6)2 [5] and [Ru(tpm)(dppz)(µ-L'2)](PF6)2 [6]. Complexes [5] 
and [6] were prepared by refluxing [Ru(tpm)(dppz)Cl]
+
 and AgNO3 in ethanol:water 
followed by the addition of the L'1 or L'2 ligand. AgNO3 was added to remove the axial 
chloride ligand and precipitated as AgCl which was removed by filtration through celite. The 
resultant complexes were precipitated as PF6ˉ salts by reducing the solvent volume and 
adding an excess of the appropriate counter ion (Figure 3.4). Both ruthenium complexes 
were further purified by column chromatography on alumina eluted with acetonitrile:toluene. 
 
 




3.3.2.2 Bimetallic complexes  
[{Ru(tpm)(dppz)}2(µ-L'1)](PF6)4 [7],[{Ru(tpm)(dppz)}2(µ-L'2)](PF6)4 [8].  
Both complexes [7] and [8] were synthesized in an identical procedure starting by refluxing 
[Ru(tpm)(dppz)Cl]
+
 and AgNO3 in ethanol:water. After filtration [(tpm)Ru(dppz)(L'1)](PF6)2 
or [(tpm)Ru(dppz)(L'2)](PF6)2 in acetone was added to the resultant solution, which was then 
refluxed for 3 days. The solution was concentrated and purification was achieved via ion-
exchange chromatography on Sephadex CM-25 resin eluted with water acetone mixtures 
(5:3) containing increasing concentrations of NaCl. The fractions containing the product were 
concentrated and the product was precipitated by addition of NH4PF6. 
 







H NMR spectroscopy studies 
 3.3.1.1 [Ru(tpm)(dppz)(µ-L'2)][(PF6)]2 
The downfield 
1
H NMR region of the spectrum for [Ru(tpm)(dppz)(µ-L'2)](PF6)2  is shown 
below in Figure 3.6 along with the molecular structure and proton labelling scheme.  
 
 
Figure 3.6: Downfield region of 400 MHz 
1
H NMR spectrum of [6] in acentonitril-d
3
 
along with chemical structure and  proton labelling scheme. 












































The 500 MHz 
1
H NMR-COSY spectrum (Figure 3.7) shows the cross coupling between the 
different ligand sets, Tpm (blue), dppz (red) and L'2 (green). 
 
The typical de-shielded methane proton of the tpm moiety is found as a singlet at 9.13ppm 
(a). Cross coupling analysis shows that the pyrazole protons appearing at 8.60ppm (b), 
6.38ppm (c) and 6.80ppm, which integrate for two hydrogen atoms each are the axial 
pyrazole and the signals as 8.63ppm (e), 7.05ppm (f) and 6.17ppm (g) (which all integrate for 
two hydrogens) are the two equatorial protons. The phenanthroline protons of dppz appear at 
9.81ppm (h), 8.21ppm (i) and 9.08ppm (j), with all three signals integrating to two protons 
each. Due to its proximity to nitrogen, proton h has the highest chemical shift. The two 
phenazine protons appear at 8.57ppm and 8.41ppm respectively. All seven sets of pyridine 
protons within the linker are rendered inequivalent due to coordination of one of the pyridine 
moieties of the (µ-L'2) ligand to the ruthenium centre. The two aromatic sets appear at 
8.06ppm (p) and 7.56ppm (z). The large coupling constant indicates that these protons are 
adjacent to ring nitrogens, and the one coordinated to the ruthenium was assumed to be with 
the furthest downfield shift. The other aromatic protons appear at 7.85ppm (n) and 7.36ppm 
(x). The two triplets at 2.55ppm and 2.60ppm which are closely positioned are protons (q) 
and (s) on the alkyl linker. While the amino group protons appear as a singlet at 2.01ppm (r), 






                    Figure 3.7: 500 MHz 
1
































































H NMR spectrum of the bimetallic ruthenium complex [{Ru(tpm)(dppz)}2(µ-
L'2)][(PF6)]4 is well resolved and is quite simple due to the symmetry of the molecule. 
Therefore, 2D-COSY NMR was not needed to fully assign the spectrum of this complex. 
 
 
3.3.2 Photophysical studies 
The photophysical properties of complexes [5-8] were recorded in acetonitrile solutions at 
room temperature (Figure 3.8). All the complexes show a band between 220-320 nm that can 
be assigned to high energy π→π* transition in aromatic nitrogen donor ligands. The UV-Vis 
spectrum of the dppz ligand in DMF shows structured transitions between 340-380 nm, 
which can be assigned to (π→π*) transitions.
2
 All complexes show A band around 360 nm; 
in [5] and [8]  this band is found at 357 nm, for [6] it occurs at 355 nm and for [7] it is seen at 
359 nm. Metal ligand charge transfer transitions (MLCT) are observed for all the complexes 
at around 400-500 nm; this is typical for ruthenium (II) complexes with coordinated 
polyimine ligands. Data are summarised in table 3.1.  
 
Figure 3.8: UV-Visible absorption spectra for the complexes [5], [6], [7] and [8] as PF6 salts in 
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The UV-Visible data for these complexes [5],[6],[7] and [8] recorded in tris buffer as their 
respective chloride salts is also summarised below in Table 3.2. The spectra for these 




Figure 3.9: UV-Visible absorption spectra for the complexes [5], [6], [7] and [8] as chloride salts in 
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Table 3.2: UV-Visible data for the complexes [5], [6], [7] and [8] as chloride salts recorded in 5mM 





3.4 DNA Binding Studies 
3.4.1 Absorption titration 
Initial evidence of these complexes binding to DNA comes from the absorption titration 
experiments. Upon addition of CT-DNA to buffered solutions of the complexes, their UV-Vis 
spectra show hypochromic and red shifts of the peak maxima in both MLCT and π→π* 
absorption bands. Figures 3.10 and 3.11 show typical UV-Vis titrations. 
 
 
Figure 3.10: UV-Visible titration of 1.01 mM bp
-1
 CT-DNA into a solution of 15 μM [6]Cl2 in 5 mM 






















Figure 3.11: UV-Visible titration of 1.01 mM bp
-1
 CT-DNA into a solution of 15 μM [8]Cl4 in 5 mM 
tris buffer, 25 mM NaCl, pH 7.4 at 25 °C. 
 
 
For all complexes, the bands at ~278 nm and ~357 nm show a high degree of 
hypochromicity. There is also a significant bathochromic shift of about ~10 nm as the band at 
~278 nm reaches saturation. Hypochromicity and bathochromic shifts generally indicate 
intercalative binding
3
 as these effects are the result of the interaction between the electronic 
states of the ligand and the DNA base pairs.
4,5
 
The saturation binding curves of [5-8] obtained from the titrations are shown in (Figure 






















Figure 3.12: Binding curves obtained from the UV-Vis titrations of [5]Cl2, [6]Cl2,[7]Cl4 and [8]Cl4  
binding to CT-DNA 
 
 
The previously described complexes [1], [2], [3] and [4] all bind to DNA with the dppz 
ligand in a solvent protected site. On the basis of the similarities in structures and absorption 
characteristics between these Ru(II)dppz complexes and complexes [5], [6], [7] and [8], it 
seems that the latter complexes bind to CT-DNA in a similar manner. 
 
 
3.4.2 Luminescence titration  
To further investigate the binding mode between complex and CT-DNA, luminescence 
titration experiment was carried out. The complexes luminescence in tris buffer with 
wavelength maxima around ̴ 640 nm, Figure 3.13 and 3.14 show the emission spectra of the 
complexes [6]Cl2 and [8]Cl4 in the presence and absence of CT-DNA. All the complexes 
have a light switch effect with emission from all four complexes being quenched by water 
molecules, while binding to DNA enhances luminescence by several orders of magnitude. All 




























case of [5]Cl2 the excitation wavelength is at 425 nm, for [6]Cl2, λex = 435 nm, and λex = 
445 and 460 nm for [7]Cl4 and [8]Cl4 respectively. The emission of [6]Cl2 and [8]Cl4 are 
around 640 nm, while  the emission of [5]Cl2 and [7]Cl4 are around 645 nm. Data are 




Figure 3.13: Luminescence titration of 1.01 mM M bp
-1
 CT-DNA into a solution of 15 μM [6]Cl2 in 5 























Figure 3.14: Luminescence titration of 1.01 mM bp
-1
 CT-DNA into a solution of 15 μM [8]Cl4 in 5 






λex (nm)                 λem (nm) 
[5]Cl2 425 645 
[6]Cl2 435 639 
[7]Cl4 445 642 
[8]Cl4 460 640 
























The binding curve for the interaction of these complexes with CT-DNA shows that saturation 




Figure 3.15: Binding curves obtained from the Luminescence titrations of [5]Cl2,[6]Cl2,[7]Cl4  and  
[8]Cl4  binding to 1.01 mM CT-DNA, 25mM NaCl, 5mM Tris-HCl, pH 7.4, 25°C 
 
 
The binding data for the luminescence and absorption titrations of these complexes again 
did not fit to the Mcghee Von Hippel model properly for the same reasons as explained in 
chapter two. To address this problem, the binding constants Kb for the interaction of these 
complexes with CT-DNA were calculated by using a simpler model.
6
 
In plots of [DNA]/ ( εa − εf) versus [DNA], Kb is given by the ratio of slope to the intercept 





























Figure 3.16: Scatchard plots for the complex [6]Cl2 (top) and complex [8]Cl4 (bottom) obtained from 















































For the two monometallic complexes [5]Cl2 and [6]Cl2 the intrinsic binding constant 
constants were determined as 4.0 × 105 M-1 and 3.0 × 105 M-1  respectively. However, the 
intrinsic binding constant constants for both dinuclear complexes [7]Cl4 and [8]Cl4 were 
obtained as 9.0 × 106 M-1 and 5.0 × 106 M-1 respectively. This shows an over one order of 
magnitude increase in binding affinity for the dinuclear over the mononuclear complexes.  
 
Complex Kb (M1-) 
[5]Cl2 4× 𝟏𝟎5 (±0.08) 
[6]Cl2 3× 𝟏𝟎5 (±0.1) 
[7]Cl4 9× 𝟏𝟎6 (±0.2) 
[8]Cl4 5× 𝟏𝟎6 (±0.3) 
Table 3.4: Binding constants obtained by UV-Visible titrations of CT-DNA with complexes [5-8], Kb 
is intrinsic binding constants.  
 
 
Since the size and shape of complexes [1-4] and [5-8] are almost identical, the increased 
binding affinity of [5-8] over [1-4] for CT-DNA must be due to the connectivity within the 
tether ligand.  
In optical titrations with mononuclear [Ru(tpm)(pyNH2)(dppz)]
n+
   complexes (where pyNH2 
= 3- or 4-amino pyridine) it was found that although the 3-pyNH2-based complex binds by 
intercalation, the coordinated 4-pyNH2 complex is a low affinity groove binder that does not 
display the light switch effect. NMR studies revealed that this is due to unfavourable 
interactions made by the 4-NH2 of the coordinated pyridine which projects into the minor 
groove of the duplex. It seems that effects like this are responsible for the different affinities 
of the systems reported in this chapter and chapter two.  
It seems clear that attachment of the chain of the tether in the 3-position of the coordinated 




In summary the spectroscopic binding studies on the ruthenium monometallic complexes 
reveal a good affinity for DNA with the dinuclear complexes showing a 10 fold enhanced 
affinity over the mononuclear complexes.  
 
 
3.4.3. Luminescence lifetimes 
Luminescence lifetimes for all the complexes [1-8] were recorded in acetonitrile. Data and 
the quality of fits to a single exponential function (X
2
) are summarised in Table 3.5. The 
longest lived lifetime among this series of complexes is around ̴ 75 ns for complex [6], 
whereas the shortest luminescence lifetime is about ̴ 53 for the complex [2] in acetonitrile. 
Foxon et al. prepared a family of substituted dppz ligands, one of which was 
[Ru(tpm)(pyridine)dppz]
2+
 with a luminescence lifetime 77 ns.
7
 This luminescence lifetime 
value correlates well with the data observed for the complexes [1-8] in acetonitrile. 
 
Complex [1][PF6]2 [2][PF6]2 [3][PF6]4 [4][PF6]4 [5][PF6]2 [6][PF6]2 [7][PF6]4 [8][PF6]4 
t (ns) 68.90 53.23 57.54 67.91 73.70 75.36 55.89 73.60 
X
2
 1.06 1.16 1.00 1.10 1.15 1.19 1.01 1.04 




3.4.4. Viscosity Measurements 
In the absence of crystallographic structural data, viscosity measurements of CT-DNA are 
considered as the least ambiguous and the most critical tests of a binding model in solution.
8,9
 
Therefore, the effect of new complexes [5-8] on the viscosity of CT-DNA has been explored 





Clearly, these new complexes produce very large positive viscosity changes, definitively 
confirming that these complexes intercalate into DNA duplex. Furthermore, these studies 
show that the 3-py based complexes [5-8] lengthen the DNA sequences appreciably more 
than 4-py based complexes [1-4] suggesting that these complexes intercalate more deeply 
than the 4-py based complexes. It is also interesting to note that the viscosity changes induced 
by [8]Cl4 is significantly larger than that of [6]Cl2. This the first time that this kind of 
dincuclear complex shows such an increase over its mononuclear analogue and suggests that 
in this case the dinuclear complexes is a true bis-intercalator.  
 
 




 of CT-DNA versus R
-1
 (R = [DNA]/[Compound]) 
upon addition of  EtBr, H33258, [5]Cl2 and [7]Cl4. Experimental conditions: 5 mM Tris, 25 mM   

































 of CT-DNA versus R
-1
 (R = [DNA]/[Compound]) upon 
addition of  EtBr, H33258, [6]Cl2 and [8]Cl4. Experimental conditions: 5 mM Tris, 25 mM   NaCl, pH 
7.4 at 26°C. 
 
In this chapter, the synthesis and characterization by UV-visible spectroscopy, luminescence 
titrations, 
l
H NMR and mass spectrometry of four new ruthenium complexes, 
[Ru(tpm)(dppz)(µ-L'1)](PF6)2 [5], [Ru(tpm)(dppz)(µ-L'2)](PF6)2 [6], [{Ru(tpm)(dppz)}2(µ-
L'1)](PF6)4 [7] and [{Ru(tpm)(dppz)}2(µ-L'2)](PF6)4 [8],  have been investigated and their 
binding with CT-DNA has been studied. Absorption titrations showed ~10nm bathochromic 
shift of the absorption band at ~ 278 nm along with significant hypochromicity. Viscosity 
measurements confirmed that the complex-DNA interaction is through intercalation. These 
results confirm that both mono and di complexes are avid binders of CT DNA and that the 
dipyridophenazine ligand on them is engaged in the intercalative interaction with DNA.  
Furthermore, in comparison with complexes [1-4] the interactions of complexes [5-8] with 
DNA are stronger. Or particular note is the fact that the dinuclear complexes show enhanced 
binding compared to their mononuclear analogues. Indeed, the viscosity measurement present 

























The results described in this study highlight how the nature and positioning of functional 
groups within the complexes affect binding affinities. Results from the isothermal titration 
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In recent years isothermal titration calorimetry (ITC) has become an increasingly popular 
technique and has found wide-ranging application in the study of chemical binding 
phenomena, especially biochemical processes. ITC is the only technique currently available 
that directly measures enthalpy changes associated with interactions. ITC can be used to 
measure the binding affinity (Ka), enthalpy changes (ΔH), entropy changes (ΔS) and binding 
stoichiometry (n) of the interaction between two or more molecules in solution. 
 
 
4.2 General principles of the ITC experimental setup 
A typical ITC instrument consists of two identical cells, one is a reference containing the 
same solvent used in the sample cell (for aqueous solution the reference cell is filled with 
distilled water) and the other, a sample cell (working cell) containing the host 
(macromolecule) for the interaction and the syringe is filled with the guest, also dissolved in 






Figure 4.1: ITC experimental schematic 
 
 
After equilibration the syringe injects a certain volume of guest solution into the host solution 
at prefixed time intervals. Upon making an injection of the guest, heat is either absorbed or 
released. These tiny heat effects produce a difference in temperature between the cells that is 
detected by semi-conductor thermopiles, and the calorimeter applies thermal power to return 
the system to thermal equilibrium. The energy difference between the two cells for each 
injection is measured and integrated and the process repeated until eventually the saturation 
point of the titration is reached. 
 
For a reaction of 1:1 stoichiometry, the following equation describes the binding equilibrium 















At any given time, the total concentration of either the macromolecule or the ligand can be written 
 
[𝑀]𝑡𝑜𝑡 = [𝑀] + [𝑀𝐿] 
Equation 4.3 
 
[𝐿]𝑡𝑜𝑡 = [𝐿] + [𝑀𝐿] 
Equation 4.4 
   










[𝑀]𝑡𝑜𝑡  + [𝐿]𝑡𝑜𝑡  +
1
𝐾𝑎 − 










































Where V is the sample cell volume and ∆𝐻° is the molar enthalpy of the binding. 
 
 




































Binding curves can be generated using equation 4.9, and therefore the binding constant and 
enthalpies for the interaction can be calculated. The free energy change for a reaction can be 
calculated from the equilibrium constant: 
 
∆G° = −𝑅𝑇 𝑙𝑛 𝐾𝑎 
 






Where ∆𝐺°is the Gibb’s free energy, R is the gas constant (R =  1.98 x10−3 kcal/mol.deg) 
and T the temperature in Kelvin (T (K) =273 + T (℃)). Finally, knowing ∆𝐺° and ∆𝐻°, ∆S° 
can be calculated by: 
 
∆G°  =  ∆𝐻° − 𝑇∆𝑆 ° 
                                                                                                                         Equation 4.11 
 
 
4.3 Titration curve and binding constant  
The shape of binding isotherm produced in the ITC experiment depends on the Wiseman c-
parameter:
1-3
 Provided that concentration is expressed as the total concentration of binding 
sites, the shape of a binding curve for macromolecules with 𝑛 identical sites will be exactly 
the same as for a molecule with a single binding site having the same 𝐾𝑎 value. To account 
for this, the 𝑐 parameter is defined as  
 
𝑐 =   𝐾𝑎[𝑀]𝑡𝑜𝑡𝑛 
                                                                                                                             Equation 4.12 
The importance of this is that the precision with which a titration curve can be simulated 
depends on the value of 𝑐 without using actual numerical values for 𝑛, 𝐾𝑎, ∆𝐻°, [𝑀]𝑡𝑜𝑡or 
[𝐿]𝑡𝑜𝑡.  
A high value of 𝑐 can result from a high concentration of macromolecule/ligand and/or a high 






Very large c values (c = ∞) lead to tight binding and the isotherm curve is rectangular in 
shape with the height corresponding directly to ∆H° and the sharp drop occurring exactly at 
the stoichiometric equivalence point n in the molar ratio. As c is decreased by reducing 
[M]tot and keeping the other parameters constant, the drop near the equivalence point 
becomes very broad transitions and the intercept at the Y-axis becomes lower than the 
true ∆H°.  
 
By deconvolution from the total area under the curve and its shape, this parameter is easily 
obtained. Very weak binding (cf. c = 0.1) yields a nearly horizontal trace, which again like 
very tight binding yields little information on the precise value of 𝐾𝑎. The shape of the 
isotherm is only sensitive to 𝑐 values in the range 1 ≤ 𝑐 ≤ 1000, corresponding to binding of 
intermediate strength. This range has been referred to as the “experimental K window”. 
When available, the middle of the window from 𝑐 = 5 to 500 is ideal for measuring 𝐾𝑎. 
Therefore, in general, the concentration of the metal complex in the syringe was kept around 








Figure 4.2: Simulated binding isotherms for various values of the parameter c 
 
 
4.4 ITC calibration  
Calorimetric techniques are uniquely exposed to systematic experimental errors. These errors 
are frequently affected by contributions from process accompanying the interaction being 
investigated. Furthermore, errors such as evaporation, condensation and incomplete mixing 
are difficult to control and include. Calibration errors are another possible contribution to 
systematic errors. Unfortunately, although there are several methods available, there is not 
commonly accepted method of calibration for ITC. Electrical calibration is the most 















provided with most ITC instruments and it releases a pulse of an accurately known quantity 
of heat by converting the electrical signal to power output. Other calibration methods used 





4.5 Heat of dilution 
The ITC data from a titration can require some correction before analysis. These background 
heats are measured in separate experiments. For example, buffer is injected into buffer to 
determine if any interaction occurs which may effect in the reaction. Ligand is also injected 
into buffer to measure the heat of dilution of the ligand and to confirm that heat changes are 
uniform throughout the titration process. Finally, buffer is injected into the macromolecular 
hosts. After these corrections, the isotherm can be fit to an appropriate model to obtain the 
binding constant and the stoichiometry.  
 
4.6 Data analysis 
 The model required to fit the data depends on the system of interest. The widely used Origin 
software typically includes functions describing equilibria for which analysis of calorimetric 
data to multiple independent binding sites is well established. More complex models, such as 
multiple co-operative binding events, require more independent variables and although 
apparent improvement of the fits can be accomplished, this does not mean that the most 
suitable model has been chosen. It should be noted that enthalpy is the only parameter that is 
model independent. Often in cases involving biological molecules more than one independent 
interaction, such as several coupled equilibria, can occur. These types of binding can be 
accommodated by software supplied with most current instrumentation and thus provide the 
enthalpies and stoichiometries as for the single site model. Usually performing the titrations 
at different temperatures will confirm the presence of two or more independent binding 
events.
6





4.7 ITC studies 
4.7.1 Set one: Complexes [1]Cl2,[2]Cl2,[3]Cl4 and [4]Cl4 titrated into CT-
DNA solution. 
To further characterise the interaction of the complexes with nucleic acids, the binding 
thermodynamics of the first set of ruthenium complexes [1-4] with CT- DNA at 25 °C were 
determined by ITC. This work was carried out at the School of Chemistry in Cardiff 
University under the supervision of Dr Neik Buurma.  
Blank titrations were performed before titrations of ruthenium complexes solutions into CT-
DNA solution were carried out.  In these blanks, each of the four ruthenium complexes were 
titrated separately into tris buffer solution, to establish whether the metal complexes exhibited 
any interactions with the buffer. No measureable heat was detected in any of the cases, other 
than that due to dilution of the ruthenium complexes. Furthermore, in similar blank titrations 
in which buffer solution was titrated into DNA solution, no heat was detected due to 
interactions between the CT-DNA and the buffer.  
In these titrations the values for the reaction stoichiometric ratios, 𝐾𝑏and 𝛥𝐻
° determined 
from simulation and 𝛥𝑆° obtained by calculation from 𝐾𝑏, and 𝛥𝐻
° are summarised in Table 
4.1, 4.2 and 4.3 and discussed in a full details later. 
 
A typical ITC trace that results from the interaction between complex [1]Cl2, and CT-DNA 



































Figure 4.3:  ITC raw data for the interaction of [1]Cl2 (1.00 mM) with CT-DNA (0.25 mM) in 5mM 
Tris, 25mM NaCl, pH 7.4 at 25 °C. 
 
 
This output is consistent with an endothermic reaction and is simulated as a single binding 
event. In this case, the interaction of this complex with CT-DNA showed a positive change in 
enthalpy (2.5 kcal mol
-1
) and positive entropy indicating that the interaction is entropically 
driven. The binding constant obtained by ITC was 6.40× 105 𝑀−1, ∆𝐻° = 2.59 kcal mol-1, 
𝑇∆𝑆 ° = 10.50 kcal mol-1 and the site size was 3.77 bp per binding event. Hydrophobic 
interactions are usually characterised by small enthalpy changes and large entropy changes.
7
 
Electrostatic interactions are more difficult to determine, but the interaction of cations with 





















































[1]Cl2 6.40× 105 3.77 2.59 -7.91 -10.50 
 
Table 4.1: ITC thermodynamic data for the interaction of [1]Cl2 with CT-DNA at 25℃ 
 
When the differential heat flow is plotted against molar ratio for titration of a 1.00 mM 
solution of [1]Cl2 into a 0.25 mM CT-DNA solution, then a comparison curve between 
experimental and calculated heat of the binding interaction can be constructed. The graph 
shows almost an identical agreement between the experimental and calculated values of the 
integrated heat effects against molar ratio.   
 


























In the interaction of [2]Cl2 and [3]Cl4  with CT-DNA, two modes of binding  (Kb1 and Kb2) 
were distinguished (Figure 4.5), both showed small positive enthalpies and positive changes 
in entropy for the first event binding, indicating that the reaction is also entropic favoured. 
The observation of two binding modes is in agreement with the data obtained from integrated 
heat effects which showed two different bindings stoichiometries for the interaction of [2]Cl2 
and  [3]Cl4 with CT-DNA (Figure 4.6). The affinities of these complexes with DNA for the 
first events are in the order of 8.95 × 105  M−1 and 4.49 × 105 M−1 and the second events 
show binding affinities in 1.23 × 105  M−1  and 3.22 × 105  M−1  ranges for the complexes 















Figure 4.5: ITC raw data for the interaction of [2]Cl2 (1.00 mM) (a) and [3]Cl4 (1.00 mM) (b) with 
























































































Figure 4.6: Integrated heat effects for titration of a 1.00 mM solution of [2]Cl2 (top) and [3]Cl4 











































The second binding events of [2]Cl2 and [3]Cl4 are endothermic in nature with a positive 
enthalpies and positive entropies term. However, [3]Cl4 showed  larger positive enthalpy and 
entropy, thermodynamic parameters for both complexes [2]Cl2 and [3]Cl4 are shown below 
(Table 4.2). Both binding events for complexes [2]Cl2 and [3]Cl4 are entropically favoured. 
 
Complex [2]Cl2 [3]Cl4 
Kb1/M(bp)
-1
 8.95× 105 4.49× 105 
S1/bp 12.77 1.99 
∆H1/kcal mol
-1
 0.59 0.47 
∆G1/kcal mol
-1
 -8.08 -7.67 
(-T∆S1)/kcal mol
-1
 -8.68 -8.68 
   
Kb2/M(bp)
-1
 1.23× 105 3.22× 105 
S2/bp 2.83 20.7 
∆H2/kcal mol
-1
 1.84 15.8 
∆G2/kcal mol
-1
 -6.91 -7.48 
(-T∆S2)/kcal mol
-1
 -8.77 -23.28 
Table 4.2: ITC thermodynamic data for the interaction of [2]Cl2 and [3]Cl4 with CT-DNA at 25℃ 
 
Again, the thermodynamic parameters obtained for [1],[2] and [3] are in good agreement with 
the data obtained by Chaires et al.
9
 for the interaction of Δ‐ and Λ‐ [Ru(phen)2(dppz)]
2+
 with 
CT‐DNA at 25 °C, where interactions are entropically driven with small positive changes in 
enthalpy, which is typical for hydrophobic interactions (as a consequence of transferring the 
dppz ligand from the aqueous solution to inside the DNA), release of counter ions and 
changes in hydration. 
 
Calorimetric data for the binding of [4]Cl4 to CT-DNA revealed one distinct binding event 
(Figure 4.7). Surprisingly, the titration curve for binding of [4]Cl4 to CT-DNA was 






, as well as a much reduced entropic term of 𝑇∆𝑆 ° = -2.66 kcal mol-1 resulting in a 
binding affinity of 9.63× 104 𝑀−1. This profile suggests that the complex is stabilized by 
hydrogen bonding as well as van der Waals interactions.  
The thermodynamic profile for the interaction of [4]Cl4 with CT-DNA is shown in the table 
below. 


















Figure 4.7: ITC raw data for the interaction of [4]Cl4 (1.00 mM) with CT-DNA (0.25 mM) in 5mM 



























































Figure 4.8: Integrated heat effects for titration of a 1.00 mM solution of [4]Cl4 into a 0.25 mM CT- 
DNA 
 
Comparing the binding affinities of the complexes [1-4] produced by ITC show that the 
monometallic complexes [1]Cl2 and [2]Cl2 bind to CT-DNA more strongly than their 
analogous dinuclear complexes [3]Cl3 and [4]Cl4. Binding parameters obtained from ITC are 



























4.7.2 Set two: Complexes [5]Cl2,[6]Cl2,[7]Cl4 and [8]Cl4 titrated into CT-
DNA solution. 
The thermodynamics of the binding of [5]Cl2, [6]Cl2, [7]Cl4 and [8]Cl4 with CT‐DNA at 25 
°C were also studied. A comparison of the enthalpic and entropic contributions to binding is 
shown in table 4.4. 
 
Complex [5]Cl2 [6]Cl2 [7]Cl4 [8]Cl4 
Kb1/M(bp)
-1
 1.74× 105 7.30 × 106 2.15× 105 4.07× 107 
S1/bp 7.81 30.03 2.10 3.34 
∆H1/kcal mol
-1
 0.22 0.27 0.917 -0.14 
∆G1/kcal mol
-1
 -7.14 -9.35 -7.24 -10.37 
(-T∆S1)/kcal mol
-1
 -7.37 -9.63 -8.16 -10.23 
     
Kb2/M(bp)
-1
 9.35× 104 3.87× 105 ….. 3.39× 105 
S2/bp 2.94 2.65 ….. 3.50 
∆H2/kcal mol
-1
 2.39 1.24 ….. -0.64 
∆G2/kcal mol
-1
 -6.77 -7.61 ….. -7.53 
(-T∆S2)/kcal mol
-1
 -9.16 -8.85 ….. -6.89 
 
Table 4.4: ITC thermodynamic data for the interactions of [5]Cl2, [6]Cl2, [7]Cl4 and [8]Cl4 with CT-








In the interactions of the complexes [5-8] with CT-DNA, two modes of binding were seen 
(Figure 4.9).  
The interaction of most of these complexes with CT‐DNA for the first event show small 
positive changes in enthalpy (from 0.22 kcal mol
-1
 to 0.765 kcal mol
-1
) and positive entropies 
indicating that the interactions are entropically driven. The exception being complex [8]Cl4 
which shows a small negative enthalpy and positive entropy indicating that the interaction is 
both enthalpically and entropically favoured. The binding affinities of these complexes are 
reasonably large with values 1.74× 105M-1, 7.30 × 106 M-1 and 4.07× 107 M-1 for [5],[6] 
and [8] respectively and corresponding binding sites of 7.81, 30.03 and 3.34. As mentioned 
before, hydrophobic interactions are usually characterised by small enthalpy changes and 
large entropy changes
10
 and electrostatic interaction are usually entropically driven with 
small unfavourable changes in enthalpy.
4  
In contrast, the titration of [7]Cl4 was best fitted to 
a one set of site model, indicating one binding event. The thermodynamic profile of [7]Cl4 
binding to CT-DNA showed a small positive enthalpy (0.917 kcal mol
-1
) and positive change 














































































































Figure 4.9: ITC raw data for the interactions of (a) [5]Cl2 (1.00 mM), (b) [6]Cl2 (1.00mM), (c) [7]Cl4 





























































































Figure 4.10: Integrated heat effects for titration of a 1.00 mM solution of [6]Cl2 (top) and 








































The second event is enthalpy and entropy favoured for the complex [8]Cl4  with enthalpy 
between -0.64 kcal mol
-1
. This negative enthalpy can be interpreted as H‐bonding and/or van 





range with binding site size of 3.50 bp per ligand. However, the second event 
interactions of [5]Cl2 and [6]Cl2 with CT-DNA are entropically driven with small positive 
enthalpies around (2.39-1.24) kcal mol
-1
 and positive entropy (T∆S2 = 9.16 and 8.85 kcal 
mol
-1
) correspondingly. Binding site sizes for this binding event are about 2.94-2.65 bp per 
ligand. A comparison of binding affinities of [5-8] observed by ITC show that, with a binding 
affinity 4.07× 107 M-1, dinuclear complex [8]Cl4 binds to CT-DNA more strongly than its 
mononuclear analogue, complex [6]Cl2, (Kb = 7.30 × 10
6 M
-1
). On the other hand, 
mononuclear complex [5]Cl2 has a binding affinity 1.74× 105 M
-1
 and therefore interacts 
with CT-DNA with a comparable strength to its dinuclear analogue [7]Cl4 which displays a 
binding affinity of 2.15× 105 M
-1
. These results are in good agreements with the data obtained 
from spectroscopic titrations and viscosity measurements discussed in Chapter three.  
In summary, the ITC evidence has been used to obtain complete thermodynamic profiles 
(∆G°, ∆H°, ∆S°) for the interaction of both sets of complexes [1-4] and [5-8] with CT-DNA. 
The results show the binding of these complexes are generally entropically favoured. The 
binding affinities of these complexes suggest that complexes [5-8] interactively bind to CT-
DNA more strongly than complexes [1-4]. Moreover, both ITC and spectroscopic studies 
show a significant increase in binding affinity for DNA for the monometallic and bimetallic 
complexes [5-8] containing 3-Py positioned tethers. These results have confirmed that the 
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In the previous chapters, the effect of the nature of linker molecule and positioning of the 
functional group within the linker on the binding affinity of a number of mono and bimetallic 
ruthenium complexes incorporating the well-characterised DNA intercalating ligand dppz 
have been discussed. A variety of techniques have been used to study the binding of this 
series of complexes with CT-DNA. In this chapter the synthesis, characterisation and DNA 
binding study of the new hetero-bimetallic Ru-Re complex bearing the same intercalating 
dppz ligand, and also homo-bimetallic Ru-Ru complexes having mixed intercalating 
dppz/dppn ligands are reported as well. 
 






The design of multinuclear metal complexes containing electroactive and photoactive units 
has attracted the attention of many research groups.
1
 The active units in these 
multicomponent systems are linked through covalent bonds and variety of organic or 
inorganic active components can be engaged. 
Many multinuclear compounds incorporating photoactive and electroactive units based on d
6
 
metal transition complexes have been constructed. In particular, ruthenium(II) and rhenium(I) 
polypyridyl complexes are popular in both fundamental studies and applications.
2,3
 Based on 
the attractive electrochemical and excited-state properties, we have synthesized a new hetero-
dinuclear dppz complex of ruthenium(II)-rhenium(I) system (Figure 5.1.1) and the electronic 


















 was synthesized from 
the known mononuclear complexes [Ru(tpm)(dppz)(µ-L1)]
2+
, described in chapter 2, and 
[ReCl(CO)3(dppz)].
4
 The reaction was started by refluxing [ReCl(CO)3(dppz)]  and 
AgCF3SO3 in ethanol overnight. The filtered solution was then returned to the reaction vessel 
followed by addition of excess [(tpm)Ru(dppz)(L1)]Cl2 in an ethanol solution. The mixture 
was refluxed overnight again, and then evaporated to obtain a red-brown precipitate. 
Purification was achieved via anion metathesis, where the compound dissolved in the 
minimum amount of acetone and converted by counter–ion metathesis using acetone 
solutions of tetrabutylammonium chloride (10 molar equivalencies). This resulted in 
precipitation of the desired chloride product, which was filtered and washed with copious 
















5.1.3.1 Absorption spectrum of ruthenium-rhenium complex 
 
The UV-visible absorption spectrum of the chloride salt of the complex was recorded in 
aqueous tris buffer at room temperature. Data are summarised in Table 5.1.1. 
 
 
Figure 5.1.3: UV-Visible absorption spectrum for the complex [9] as a chloride salt in in 5 mM tris 
buffer, 25 mM NaCl, pH 7.4 at room temperature 
 
 
The UV/Vis absorption spectrum of [9]Cl3 in aqueous tris buffer shows high-energy π→π* 
transitions at 276 and 317 nm. Below 320 nm, a superposition of metal(dπ)→dppz(π*) 
MLCT and dppz(π→π*) intraligand (IL) transitions is observed.
5-8
 Excitation at 431 nm 
results in unstructured luminescence characteristic of the Ru(dπ)→dppz(π*) 
3
MLCT 


































































π → π* 
π → π* 






Table 5.1.1: UV-Visible data for the complex [9] as a chloride salt recorded in 5mM tris buffer, 25 
mM NaCl, pH 7.4 at 25 °C. 
 
 
The data for complex [9] recorded in acetonitrile as a PF6 salt is also summarised below in 
Table 5.1.2. The absorption spectrum for this compound is shown in Figure 5.1.4.  
 



















































π → π* 





Table 5.1.2: UV-Visible data for the complex [9] as PF6 salt recorded in acetonitrile at 25 °C. 
 
 
5.1.4 DNA Binding Studies  
5.1.4.1 Absorption titration 
The interaction of [9] with calf-thymus DNA (CT-DNA) in aqueous buffer (25 mM NaCl, 5 
mM tris buffer, pH 7.4) was investigated using electronic absorption spectroscopy.  Addition 
of aliquots of CT-DNA results in distinctive changes in the UV/Vis spectrum of [9], with 
several bands between 279 and 490 nm showing large hypochromicity and significant 








Figure 5.1.5: UV-Vis titration of 1.01 mM bp
-1
 CT-DNA into a solution of 50 μM [9]Cl3 in 5 mM tris 
buffer, 25 Mm NaCl, pH 7.4 at 25 °C.  
 
 
To parameterise the interaction of complex [9] to DNA, changes in the 279 nm band were 
followed and the binding curve for [9] was constructed, Figure 5.1.6. It showed that 







Figure 5.1.6: Binding curve obtained by UV‐Vis titrations for [9]Cl3 binding to CT‐DNA 
 
The binding constant for the interaction of the complex [9] with CT-DNA was calculated 
using previously derived, much used model
9
 in which a plot of [DNA]/(εa-εf) versus [DNA] 




 complex is used to give an estimate of the 
intrinsic binding constant (Kb). 
 
















































The binding affinity for the interaction of complex [9] with CT‐DNA was estimated as 7x104 
M
-1
. This value is lower than that of the corresponding dinuclear tetracation 
[{Ru(tpm)(dppz)}2(µ-L1)]
4+
 [3]Cl4 (Kb= 2× 𝟏𝟎5 M
-1
). The lower cationic charge of [9], 




5.1.4.2 Luminescence titration 
As expected, the emission intensity around 645 nm increases on the presence of DNA. The 
complex shows a true light switch effect, with no luminescence in aqueous solution, until 
addition of DNA to [9], causes the intense luminescence of [9] to be restored (Figure 5.1.8). 
 
 
Figure 5.1.8: Luminescence titration of complex [9] with CT-DNA. (5 mM Tris buffer, 25 mM NaCl, 






The binding curve for the interaction of the complex with CT-DNA shows that saturation 
binding has taken place, however attempts to fit this data to the commonly employed 
McGhee-von Hippel model were unsuccessful. 
 
Figure 5.1.9: Binding curve showing the luminescence titrations of [9]Cl3 binding to CT-DNA 
 
 
5.1.4.3 Isothermal Titration Calorimetry (ITC) 
To further characterise the interaction of the complex with nucleic acid, the thermodynamic 
parameters of the binding of [9] with CT-DNA was determined using ITC.
10
 
The differential heat flow and derived integrated heat effects of [9] are shown in Figure 
5.1.10 and the thermodynamic parameters are summarised in Table 5.3. 
The data for [9] shows two experiments merged together to complete the binding isotherm, 
the syringe was refilled with ligand and the titration continued immediately. The small gap 
between experiments cannot be corrected due to the removal and replacement of the syringe 
from the cell. The titrations were not able to be completed in one experiment due to the fact 













































[9]Cl3 7.58× 104 1.30 1.65 -6.65 -8.29 
 
Table 5.1.3: ITC thermodynamic data for the interaction of [9]Cl3 with CT-DNA at 25℃ 
 
 
The overall thermodynamic picture that appears from calorimetry experiment for the 
interaction of [9] with CT-DNA is that the binding is enthalpically unfavourable 





















ITC for [9] is in good agreement with the binding value obtained from spectroscopic 





 complex [3] and further illustrating that electrostatic effects make an 
appreciable contribution to overall binding. However, the DNA binding affinity Kb value of 
[9] also represents less than an order of magnitude decrease in binding affinity relative to that 








 reported by 
Simon P. Foxon and co-workers.
11
 It seems that the more extended length or the presence of 
two amino groups within the linker has an effect on the binding affinity of this system.  




 dppz complex 
binds to duplex DNA with good affinity and displays both DNA light switch and cleavage 
properties.
11
 On the basis of their report, the possibility that complex [9] could also display 
similar properties was investigated.  
 
5.1.5 RuRe Phototoxicity 
For many years the use of nucleic acid cleavage agents as structural probes and therapeutic 
agents has been studied. Some photocleavage compounds can react directly in an 
electronically excited state with a nucleic acid and cause an immediate scission of the nucleic 
acid chain. However, other compounds have excited states that indirectly lead to cleavage or 
damage of the nucleic acid.
12
 In these latter cases, to fully reveal the sites and extent of 
damage, the nucleic acid must be subjected to a secondary treatment, such as incubation with 
hot piperidine. 
The potential use of transition metal complexes as DNA structural probes and as anticancer 
agents have received significant attention.
12
 Ruthenium (II) polypyridyl complexes are 
among these complexes and they have been extensively studied due to their rich 
photophysical, photochemical and redox properties.
13 
It has been confirmed that many Ru
II
 






The diversity of the chemical structures that are readily available through 
modifications of the coordinated ligands makes Ru(II) polypyridyl complexes that 








Figure 5.1.13: Structure of [Ru(bpy)(dpb)(dppn)]
2+
 (bpy = 2,2’-bipyridine, dpb = 2,3-bis(2-





In addition to that, previous work on rhenium-based complexes has shown that they can 
produce photo-activated DNA damage as well. The intercalative binding interaction of 
[Re(dppz)(CO)3(py)][SO3CF3] and [Re(dppn)(CO)3(py)][SO3CF3] with calf thymus DNA has 
previously been studied (Figure 5.1.14).
17
 The complexes have been established to stimulate 




Figure 5.1.14: Structures of DNA cleavage molecules [Re(dppz)(CO)3(py)][SO3CF3] (A) 





Irradiation of the plasmid pBR322 DNA in the presence of both complexes indicated that 
singlet oxygen was not involved in the cleavage process. For the dppz complex A, direct 
oxidation of DNA plasmid by the excited state of the molecule was involved.
18
 For the dppn 
complex B, inhibition of cleavage in a degassed solution or through the presence of an 
appropriate quencher indicated that the superoxide radical (O2
•-
) was involved in this process; 
although the hydroxyl radical (
•
OH) was also implicated, as in the presence of hydroxyl 
scavengers decreased cleavage activity was also observed.
17
  
Moreover, the photophysical studies of Re(dppz) (A) derivatives indicated that the lowest 
excited state is an intraligand triplet state of dppz 
3
ILdppz. The difference in the photophysical 
properties of the rhenium types and the analogues Ru(II) and Os(II) with dppz arises as a 
result of the metal to ligand charge transfer states, dπ (M) → π* (dppz) 
3
MLCT. In the Re(I) 
system the 
3
MLCT state is at higher energy which allows the low-lying dppz-based 
intraligand triplet state 
3
ILdppz to dominate the photophysics of the system.
7
  In addition, 





(dppz)} unit supplies the light-switch function while the {Re
I
(dppz)} 
unit cleaves DNA.    
 Although the DNA binding properties of bis-intercalator complex [9] have been studied 
above, its potential as a DNA photocleaving agent or as a phototoxic species is discussed in 
the next section. 
 
5.1.6 DNA Photocleavage 
 Previous studies have shown that Re
I




 complex reported by the 
Thomas group - can directly cleave DNA. So this issue was investigated using complex [9]. 
This possibility was first studied through DNA cleavage experiments 
To detect DNA fragments produced by photocleavage two electrophoretic methods are 
generally used.
19
 In one case, the target is supercoiled DNA. Single strand cleavage 
(“nicking”) converts the supercoiled DNA to a relaxed, circular form whereas double-strand 
cleavage produces linear DNA. The three forms are quickly separated on an agarose gel and 
detected by fluorescent staining.  
In the second more informative method, the use of end-labeled targets is used to analyse 





terminus of one strand with a radioactive, fluorescent, or chemiluminescent tag. A 
sequencing ladder of the labelled nucleic acid is then obtained by either chemical or 
enzymatic methods. 
Photocleavage of the nucleic acid produces shorter strands that will migrate faster than the 
uncleaved target in polyacrylamide gel electrophoresis. The nucleotide at which the cleavage 
event took place can be identified by running the sequencing ladders in adjacent lanes on the 
gel. Due to its convenience, the former method described above is used, as only evidence of 
DNA cleavage was required at this early stage of study. 
Nucleic acid fragments are mostly separated using electrophoresis through agarose or 
polyacrylamide gels. The cleavage reaction of plasmid DNA can be checked by agarose gel 
electrophoresis. Relatively fast migration will be observed for the intact supercoiled form 
(Form I) when circular plasmid DNA is subject to electrophoresis. The supercoil will relax to 
generate a slower moving open circular form (Form II) if scission occurs on one strand 
(nicking). If both strands are cleaved, a linear form (Form III) will be generated that migrates 
between Forms I and II (Figure 5.1.11).
20
 Occasionally, if the cleaving agent is very active 
only small, very fast moving, fragments will be created and no plasmid will be observed. 
Single stranded cleavage of the sugar-phosphate backbone of double stranded DNA 
(“nicking”) is known to be induced by numerous organic and inorganic based systems. An 
excellent review by Armitage
12
 discusses an enormous number of these. 
 
 
Figure 5.1.11: Agarose gel picture: (1) 1kb DNA Ladder; (2) Photoactivated cleavage of the plasmid 






The DNA photocleavage property of [9] was investigated using supercoiled pBR 322 plasmid 
DNA and analysed by electrophoresis on an agarose gel. Figure 5.1.12 shows a typical 
agarose gel photo of pBR 322 treated with [9] over a range of concentrations (10, 20 and 40 
μM), irradiated for 60 mins at 470 nm. However, the gel photo showed no evidence of 
nicking at all. The experiment has repeated twice and the same result was obtained.  
 
 
Figure 5.1.12: Photocleavage of supercoiled pBR322 DNA (0.1 μg/μL) by [9] under illuminated 
condition  ( 470 nm, 100 mW, 60 minutes exposure) in 50 mM Tris-HCL buffer. Lane 1, DNA 
control; lane 2, DNA + 9 (10 µM); lane 3, DNA + 9 (20 µM); lane 4, DNA + 9 (40 µM) no nicking 
was observed.  
 
 
These observations are surprising given the previous results described by Foxon, et al and 
suggests that the Re
I
(dppz)-based excited state is too short-lived to produce DNA damage. 
This is consistent with a faster rate of energy transfer to the Ru centre in 9 compared to the 
previously reported RuRe system, an effect that is perhaps mediated by the amino groups in 




5.1.6.1 Phototoxicity of RuRe bis-intercalator towards A2780 and A2780cis 
cell lines 
In addition to the differences in photophysical properties and the charge differences of 
ruthenium and rhenium systems, it was of interest to see if they possess any biological 





activity. Thus, although it did not cleave DNA in cell-free conditions, the potential in cell 
phototoxic activity of complex [9] was also investigated. 
The phototoxic index (PI) is a comparative measure of phototoxic activity for a molecule 




To further investigate, the possible phototoxicity of complex [9] and its effects on A2780 and 
A2780cis human ovarian cancer cell lines was investigated by Dr. Paul Jarman (A fellow 
member of the Thomas group). The 48 hour IC50 determination protocol was originally used 
but four separate plates were employed and each was irradiated after 24 hours for a varying 
length of time. Three plates underwent timed exposures in the Light Irradiation Source 
Apparatus (LISA), which is used to irradiate the samples, while a dark control remained in 
the incubator throughout. To provide a comparison in assessing any phototoxicity upon 
irradiation, the dark control was essential. Untreated control wells served the usual purpose of 
delineating maximum cell viability. Besides, they could be used not only to make curves 
showing the effect of increasing compound concentration on cell viability, but - through 
inclusion in each plate individually - they also acted as a control for any damaging effects of 
the radiation alone. This confirmed the experiment was internally controlled for each variable 
and prevented any false positive results in which increased exposure to the irradiation 
increased toxicity despite of compound treatment.  
Using a range of concentrations (0.1-200 µM), the IC50 value of the complex [9] was 
determined after 48 hour to evaluate its influence against A2780 and A2780cis cell lines. The 
IC50 value against the A2780 cell line was determined as 11 µM, which is not as powerful as 
cisplatin (ca. 2 µM) but still comparatively active in therapeutic terms. However, against 
A2780cis, the IC50 of 21 µM is only a two-fold reduction in potency versus A2780 so that it 












Figure 5.1.15: Cell viability data for RuRe complex [9] 
 
 





























 A2780 with [9]Cl
3
 















Percentage Viability at 100 μM [M] 
(% cells metabolising MTT +/- 1 SD) 
0 112 53 +/- 2 
5 89 48 +/- 5 
15 58 42 +/- 4 
30 58 37 +/- 4 
 
Figure 5.1.16: A2780cis cell viability data for complex [9] upon irradiation 
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The phototoxicity of the RuRe complex against A2780cis cell line was carried out by using a 
concentration range of 1-200 µM. The result shows no significant increase in toxicity against 
A2780cis after exposure to light. Thus, based on this characteristic, complex [9] is not a 
favourable lead for applications involving PDT; this is probably due to the low oxygen 
sensitisation observed in the previous section. Nevertheless, its dark toxicity – particularly 
against cisplatin resistant cells – indicates that it is a promising therapeutic lead. To further 
explore this issue, additional substantial biological investigations will be required.          
 
In summary, the new hetero-dinuclear dppz complex is reported. The interaction of complex 
[9] with double-stranded calf thymus DNA has been studied by absorption and emission 
titrations. The complex binds to the duplex by intercalation with good affinity and displays a 
DNA light switch effect but not DNA cleavage properties. The thermodynamic parameters 
showed that the complex-DNA interaction is enthalpically unfavourable and entropically 
favoured. Moreover, although the molecule does not display significant phototoxicity, with a 



















 Polypyridyl complex with mixed-bis-intercalating 
ligands (dppz-dppn)  
5.2.1 Introduction 
In an attempt to explore new systems with different properties, mono and dinuclear 
ruthenium complexes containing a longer intercalative motif dppn were targeted. The purpose 
of this research was to investigate the effect of an increase in intercalative surface area has on 
DNA binding and spectroscopic parameters of dinuclear systems. Moreover, the known 




(dppn)] units prompted us 




5.2.2 Synthetic Studies 
5.2.2.1 Ligand synthesis 
Benzo[i]dipyrido[3,2‐a:2’,3’‐c]phenazine, (dppn) was prepared by condensation of 1,10‐
phenanthroline‐5,6‐dione (dpq) with 2,3‐diaminonaphathalene in methanol22 (Figure 5. 2.1). 
 
 








5.2.2.2 Synthesis of complexes 
 [Ru(tpm)(dppn)(L1)][PF6]2 (10) and [{Ru(tpm)dppn}2L1][PF6]4 (11) 
[Ru(tpm)(dppn)Cl]PF6 was used as a starting material to prepare complexes [10], [11] and 
[12]. It was obtained by refluxing Ru(tpm)Cl3 with dppn ligand in ethylene glycol at 120°C 
for 18 hours.
23
 The solution was filtered through celite and the complex was precipitated by 
addition of saturated solution of NH4PF6.  
The removal of the chloride ligand in [Ru(tpm)(dppn)Cl]
+
 was accomplished by refluxing 
with silver nitrate for 2 hours in ethanol:water (3:1). The target complex 
[Ru(tpm)(dppn)(L1)]
2+
 [10] was then synthesised by addition of the L1 ligand and refluxing 
for 72 hours. Precipitation of the complex occurred by addition of NH4PF6. It was then 
collected by centrifuging (Figure 5.2.2).  
In addition, complex [{Ru(tpm)dppn}2L1]
4+
 [11] was also synthesized. First 
[Ru(tpm)(dppn)Cl]
+
 and AgNO3 were heated to reflux in ethanol:water, then the filtrate 
solution was returned back to the reaction vessel and a solution of [10] in acetone was added 
to the reaction mixture and refluxed for 3 days. Precipitation of the product occurred by 
addition of NH4PF6, it was then collected by centrifuging and washed with water and diethyl 







Figure 5.2.2: Synthesis of [Ru(tpm)(dppn)(L1)][PF6]2 (10) and [{Ru(tpm)dppn}2L1][PF6]4 (11) 
 
 
Heteroleptic dinculear complex [Ru(tpm)dppz-L1-Ru(tpm)dppn][PF6]4  (12) was prepared 
in an identical manner to complex (11), except replacing the monomeric complex [10](PF6)2 







Figure 5.2.3: Synthesis of [Ru(tpm)dppz-L1-Ru(tpm)dppn][PF6]4 (12) 
 
5.2.3 Characterization 
5.2.3.1 Absorption spectra  
The UV-visible absorption spectra of complexes [10][PF6]2, [11][PF6]4 and [12][PF6]4 were 
recorded in acetonitrile at room temperature. The absorption spectra are shown in Figure 








Figure 5.2.4: UV-Visible absorption spectra for the complexes [10], [11] and [12] as PF6 salts 






































Table 5.2.1: UV-Visible data for the complexes [10], [11] and [12] as PF6 salts recorded in 
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The data for these complexes recorded in water as their respective chloride salts is also 




Figure 5.2.5: UV-Visible absorption spectra for the complexes [10], [11] and [12] as chloride salts 





































Table 5.2.2: UV-Visible data for the complexes [10], [11] and [12] as chloride salts recorded in 5mM 




The absorption bands centred at 250 and 260 nm are assigned to dppn based intraligand (IL) 
π → π* transitions. These bands appear unique to the dppn ligand as they have not been seen 
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also shows the presence of these bands,
24
 as well as that of the dominant band around 320 
nm, and they are assigned to π → π* transitions. The UV−Visible spectrum of the dppz 
ligand in acetonitrile exhibits a moderately intense band in the near-UV with two principle 
maxima at  = 358 and 376 nm, which are characteristic of π→π*(dppz) transitions. 
Therefore, the intense band at 361 nm for complex [12] is characteristic of π→π*(dppz) 
transitions. The absorption spectrum of the free dppn ligand in acetonitrile is shown to have a 
similar ‘double humped’ absorption in the near-UV region with maxima at λ = 390 and 411 
nm.
23
 Therefore, these peaks at 387 and 406 nm have been assigned as analogous dppn-based 
transitions. These transitions are more clearly seen when looking at the spectrum of the 
chloride salt which shows these peaks individually at 387 and 406 nm, as well as when 
observing the spectrum of the starting complex, [Ru(tpm)(dppn)Cl]
+
. The bands around 450 




Complexes [10] and [11] do not display the characteristically intense 
3
MLCT based 
luminescence in both acetonitrile and water. However, complex [12] does display a change in 
emission spectrum around ̴ 640 nm upon addition of CT-DNA. 
 
 
5.2.4 Transient Absorption Studies 
The study of the photoexcitation properties of ruthenium polypyridyl complexes have proven 
to be suitable in furthering the understanding of both energy and electron-transfer 
processes
16,26,27  
and in the design of applied photoconversion systems.
28-31
 The metal-to-
ligand charge transfer (MLCT) transition is most often the process of interest in these 
complexes, in which a formal oxidation and reduction reactions of the metal and the ligand 
occurs upon photoexcitation. Studies suggest that the photoexcited electron of mixed ligand 
type complexes is localized on the lowest energy ligand, at least on long (> nanosecond) time 
scales.
32-36
 However, the relaxation processes which lead to the formation of this state are not 
well understood. To this end, transient absorption studies on the new complexes were 
performed by Dr. Stuart Archer (a fellow member of the Thomas group). The transient 































Figure 5.2.6: Transient absorption spectra of complexes [3]4+,[11]4+ and [12]4+ at different time 
delays after the laser excitation with a 355 nm in CH3CN. 
 
 
Excitation of solutions of all three complexes at 355 nm with a 7 ps laser pulse leads to the 
formation of several distinctive transients due to bleaching of the absorption bands of the 






 are completely unmatched; 
these data imply that the lowest excited state detected on the picosecond time scale is not the 
same in all cases. The observed transient spectrum of complex [3] are characteristic of  dppz-
based MLCT absorption, which is in a good agreement with the fact that the lowest triplet 
excited state in complex [3] is 
3
MLCT states with abroad absorption at ̴ 600 nm.  
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However, the transient absorption spectrum of complex [11] differs significantly from that of 
[3] and [12] due to the fact that the lowest triplet excited state in complex [3] is localized on 
the 
3
ππ* of the dppn with absorption at ̴ 540 nm rather than 
3
MLCT.  
Interestingly, in the presence of both dppz/dppn ligands in the same complex [12], the 






ππ* absorption grows at   540 nm as well as a broad 
3
MLCT absorption 
around ̴ 600 nm. This study reveals that Ru
II
(dppz) systems exhibit an 
3
MLCT lowest excited 
state, however 
3
ππ* is the lowest excited state of all  the Ru
II
(dppn) complexes, which is 
similar to the previously reported data for related systems.
37
 In future work these studies will 
be extended to longer time window so as to investigate the lifetimes of - and the dynamic 




5.2.5 DNA binding studies 
5.2.5.1 UV‐Vis titrations 
To measure the interaction of metal complexes with the DNA double helix, changes in their 
UV‐Vis spectra were used. Changes in the UV‐Vis spectra of [10], [11] and [12] upon 
addition of CT‐DNA are shown in Figures 5.2.7, 5.2.8 and 5.2.9 respectively. In all cases, 
upon addition of DNA, the complexes showed several bands shifting to longer wavelengths; 
changes that were often accompanied by decreases in intensity until saturation is reached. 
These hypochromicity and bathchromic effect are typical for the stacking of aromatic ligands 









Figure 5.2.7: UV-Vis titration of 1.25 mM bp
-1
 CT-DNA into a solution of 15 μM [10]Cl2 in 5 mM 
tris buffer, 25 Mm NaCl, pH 7.4 at 25 °C.  
 
Figure 5.2.8: UV-Vis titration of 1.25 mM bp
-1
 CT-DNA into a solution of 15 μM [11]Cl4 in 5 mM 












































Figure 5.2.9: UV-Vis titration of 1.25 mM bp-1 CT-DNA into a solution of 15 μM [12]Cl4 in 5 mM 
tris buffer, 25 Mm NaCl, pH 7.4 at 25 °C.  
 
 
Binding curves for the interaction of [10], [11] and [12] with CT-DNA, following the 
changes in the 320 nm and 314 nm bands for both [10] and [11] complexes respectively 
(Figure 5.2.10), and 280 nm of [12] (Figure 5.2.11) were constructed. They all showed that 



























Figure 5.2.10: Binding curves obtained by UV‐Vis titrations for [10]Cl2 (blue) and [11]Cl4 (red) 




















































5.2.5.2 Luminescence titrations 
As mentioned above, both complexes [10] and [11] showed no emission in acetonitrile and 
also in aqueous solution upon addition of CT‐DNA. These observations agree with previous 
studies showing that the lowest excited state of the Ru(dppn) moiety is not the MLCT 
observed in Ru(dppz) systems but a non-emissive dppn-based 
*
 state. In these previous 
studies, this state was found to be quenched by O2, making these systems highly efficient at 
sensitising triplet to singlet oxygen conversion.  In contrast, the emission spectrum of 
heteroleptic complex [12] does display a change in emission properties upon addition of CT‐
DNA. Clearly, due to the presence of the {Ru
II
(dppz)} unit, complex [12] does show a 
molecular light switch effect (Figure 5.2.12) in which Ru(dπ)→dppz (π*) 
 3
MLCT appears to 
dominate the excited state of the complex, an observation that is consistent with the TA 
studies described previously. 
 
 
Figure 5.2.12: Luminescence titration of complex [12] with CT-DNA. (5 mM Tris buffer, 25 mM 



























The binding curve for the interaction of [12]Cl4 with CT-DNA are shown in Figure 5.2.13. 




Figure 5.2.13: Binding curve obtained by Luminescence titration for [12]Cl4 binding to CT‐DNA 
 
 
Again, the binding constant for the interaction of these complexes with CT‐DNA were 
calculated by using the simple Wolfe model
9
 instead of the Mcghee Von Hipple model as the 
luminescence and absorption titrations data did not fit to the later model. The binding 




























Figure 5.2.14: Scatchard plots for the complex [10]Cl2 (top) and complex [11]Cl4 (bottom) obtained 
from the absorption spectroscopy of CT-DNA.  Inserted plot, [DNA]/(εa-εf) versus [DNA] for the 
absorption titrations.  
Kb = 2X10


















































Table 5.2.3: Binding constants and binding site sizes obtained by UV-Visible titrations of CT-DNA 
with complexes [10]Cl2,[11]Cl4 and [12]Cl4. Kb is the intrinsic binding constant. 
 
 
Binding constants for the interaction of both complexes [10] and [11] with CT‐DNA are 
similar to other Ru(II)‐dppz complexes.41-43 Increasing the surface area of the intercalator was 
expected to improve the affinity of complexes for DNA, unfortunately complex [11] shows 
an affinity for CT‐DNA that is very similar to the analogous complex with dppz (Kb = 
2× 1𝟎5  M ̄¯1 for the interaction of [{(tpm)Ru(dppz)}2(L1)]
4+
 with CT‐DNA, see chapter two). 
In fact, complex [10] actually shows an affinity to DNA that is one order of magnitude lower 
with respect to the analogous dppz complexes. More interestingly, hetero-intercalator 
complex [12] has a binding constant around one order of magnitude higher than that obtained 
for dicationic octahedral complexes of dppz and is the largest observed for any of the 
dinuclear systems synthesized by the Thomas group. 
 
5.2.6 Singlet oxygen quantum yield 
Ruthenium (II) polypyridyl complexes with DNA photocleavage activity have received 





 polypyridyl complexes that are active through a 
1




[10]Cl2 2 × 104 (± 0.9) 
[11]Cl4 6 × 105
 
(± 0.2) 





confirmed to possess DNA photocleavage activities. However, their applications in 
photodynamic therapy are limited, especially when the absorption maximum of the metal-to-
ligand charge-transfer (MLCT) transition is shorter than 500 nm. Ligands can provide Ru 
complexes with longer MLCT absorption by their delocalized π systems.
44,45
 However, as 
predicted by the energy-gap law,
46
 a lower energy gap often leads to a shorter excited-state 
lifetime, which is unfavourable for 
1
O2 generation.  
That said, previous work has shown that complexes with the dppn ligand can cleave DNA. 
For example, the ability of this ligand to produce sensitised oxygen when coordinated to Ru
II
 
metal centres has been studied by the Thomas group,
47
 these studies showed that oxygen 
sensitising yields of around 70 - 83% can be achieved. This is due to population of the ligand 
centred (LC) π-π* transition acting as the sensitiser for singlet oxygen.
25
 Such metallo-
intercalator systems could possibly be useful in therapeutic systems such as photodynamic 
therapy. Thus the 
1
O2 quantum yields of [3], [11] and [12] were determined in acetonitrile at 
355 nm by a collaborator Luke McKenzie in the Weinstein group. The 
1
O2 quantum yields 
were measured to be 0.0494 for [3], 0.6721 for [11] and 0.1568 for complex [12]. As 
expected, the 
1
O2 quantum yield of complex [11] is almost four times larger than that of [12] 
and thirteen times higher than that of [3], this higher value obtained for complex [11] is 
assigned to the excited state being dominated by the ππ* triplet state of dppn ligand. The 
1
O2 
quantum yields data are summarised in Table 5.2.4.   
 
 
Table 5.2.4: Quantum yield of singlet oxygen production of [3],[11] and [12] measured in 




Compound [3] [11] [12] 





5.2.7 DNA photocleavage and Singlet Oxygen Production 
Given the promising singlet oxygen data, the DNA photocleavage properties of [10] and [11] 
were investigated using supercoiled pUC57 plasmid DNA and analysed by electrophoresis on 
an agarose gel. Changes in pUC57 plasmid DNA are detected, either when irradiated in the 
absence of ruthenium complex or when incubated with the sensitizer in the dark. The 
photocleavage efficiency depends on the structure of the metal complex. After irradiating 
plasmid DNA in the presence of [10] and [11], the supercoiled native form (I) completely 
disappears. This seems to be because both [10] and [11] complexes cleave the DNA strands 
into very small, fast moving fragments (Figure 5.2.15). 
 
 
Figure 5.2.15: Photocleavage of supercoiled pUC57 DNA (0.1 μg/μL) by [10] and [11] under 
illuminated condition  ( 470 nm, 100 mW, 30 minutes exposure) in 50 mM TAE buffer. Lane 1, DNA 
marker; lane 2, DNA control; Lane 3, DNA + 10 (20 µM); lane 4, DNA + 11 (20 µM) 
 
 
In order to explore how the exposure timing affected photocleavage process, the 
photocleavage experiment was examined under the same condition except the samples were 
irradiated for a shorter time 5 minutes. However, the same result was observed.  
 
 
1 2 3 4 






To activate a molecule and yield an effective drug with spatial and temporal selectivity by the 
use of visible light is the aim of photodynamic therapy (PDT).
48-50 
The general principle of 
PDT is based on a photosensitizer (PS), ideally a nontoxic molecule with a higher affinity for 
cancer cells over healthy cells, that can be excited by irradiation with light and then enter a 
triplet excited state through intersystem crossing. In this state, the PS can react with a 
substrate or solvent molecule, through hydrogen atom or electron transfer, generating 






The cellular phototoxicity of complexes [10], [11] and [12] was evaluated with human 
ovarian cancer cell lines, A2780 and A2780cis, using laser irradiation at 420 nm. The cells 
were exposed for 24 h using a concentration range of 1–100 µM for each complex resulting 
in the phototoxic effects shown in Figures 5.2.16 and 5.2.17. This study was done by Dr. 
Paul Jarman (a fellow member of the Thomas group) using the A2780 cell line. At low 
concentrations (10 µM) and exposure to light, both complexes [10] and [11] produced rapid 
decreases in cell viability leading to nearly total cell death after an exposure to light 
intensities above 15 Jcm
-2
. IC50 values (where IC50 = concentration required to kill half of the 
cells) for both complexes were calculated. With a decrease in IC50 values from 32 μM and 20 
μM for complexes [10] and [11] in the dark to 1.8 μM and < 0.1 μM for both complexes 
respectively after an exposure of 15 Jcm
-2
 this cell line showed a considerable phototoxic 
response. However, somewhat surprisingly, complex [12] also induced a dramatic decrease in 
cell viability with exposure to higher concentrations and longer irradiations. The IC50 value 
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) [10] IC50 (μM) [11] IC50 (μM) [12] IC50 (μM) 
0 32 20 60 
7.5 4 2.8 50 
15 1.8 < 0.1 20 
 
Figure 5.2.16: A2780 cell viability data for complexes [10], [11] and [12] upon irradiation 
 
The activity of the complexes [10], [11] and [12] against the cisplatin resistant A2780cis cell-
line was also investigated using the same protocol, over a 1–200 µM concentration range. 
With a decrease in IC50 values from >100 μM ([10]), 50 μM ([11) and >100 μM ([12]) in the 
dark to < 0.1 μM for complexes [10] and [11], and 7.2 μM for complex [12] after an exposure 
of 15 J cm
-2




































Significantly, this cisplatin resistant cell line showed a much greater phototoxic response than 
its cisplatin sensitive analogue. Again, complexes [10] and [11] showed higher phototoxicity 
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) [10] IC50 (μM) [11] IC50 (μM) [12] IC50 (μM) 
0 >100 50 >100 
7.5 1.6 3 25 
15 < 0.1 < 0.1 7.2 
Figure 5.2.17: A2780cis cell viability data for complexes [10], [11] and [12] upon irradiation 
 
 
In summary, all three complexes have been investigated for phototoxicity show a high 
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the table 5.2.5. Mononuclear complex [10] is phototoxic against both cell lines although it 
displays a better PI against A2780cis. Notably it is not really toxic at all in the dark. In 
addition, dinuclear complex [11] is phototoxic against both cell lines, but again it displays a 
better PI against the A2780cis line. Finally, complex [12] is phototoxic against both cell lines 
but has a much higher PI against A2780cis. 





5.2.8.1 Inductively coupled plasma mass spectrometry (ICP-MS) 
The differences in cytotoxicities, of the complexes [10-12] could be dependent on both their 
singlet oxygen quantum yields and their contrasting cellular uptake properties. To accurately 
quantify intracellular distribution studies of metal content within a population of cells, 
inductively coupled plasma mass spectrometry can be used.
53
 A2780cis cell line was 
incubated for 1, 3 and 24 hours with 50 µM concentrations of each complex. This analysis 
confirmed that intracellular concentrations of the dinuclear ruthenium complexes are much 
higher compared to that of the mononuclear complex, indicating that dinuclear ruthenium 
complexes [11] and [12] are being taken up better into cells than mononuclear complex [10]. 
Moreover, these results showed clear evidence that, after 24 hours, the dinuclear dppn-ddpn 
complex [11] is taken up into cells with a 9.3-fold increase in terms of molarity over a dppn-
dppz system such as [12] Figure 5.2.18. 
Complex 
A2780 
dark IC50 (µM)       light IC50 (µM) 
PI 
A2780cis 
dark IC50 (µM)        light IC50 (µM) 
PI 
[10] 32 <0.1 17.77 >100 <0.1 1000+ 
[11] 20 <0.1 200+ 50 <0.1 500+ 











To sum up, mono and dinuclear ruthenium complexes containing a longer intercalative motif 
dppn, as well as a dinuclear ruthenium system with mixed-bis-intercalating ligands (dppz-
dppn), have been synthesized.  The DNA binding properties of these complexes have been 
investigated. It was found that the mono and dinuclear complexes [10] and [11] bound to 
DNA with affinities that are at the same order of magnitude or lower with respect to their 
analogous dppz complexes. However, hetero-intercalators complex [12] had the largest 
binding constant observed for any of the dinuclear systems synthesized in our group. 
Complexes [10] and [11] do not display 
3
MLCT based luminescence in both acetonitrile and 
water. However, complex [12] does display a change in emission spectrum around ̴ 640 nm 
upon addition of CT-DNA. The 
1
O2 quantum yields of these systems revealed that complex 
[11] has a higher quantum yield value compared to complex [12]. Furthermore, the DNA 
photocleavage properties of [10] and [11] were investigated. The results showed that in the 
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appears to be because both [10] and [11] complexes cleave the DNA strands into very small, 
fast moving fragments. All three complexes have high phototoxicity indices against both cell 
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6.1 Chapter 2: Bimetallic DNA Metallo-intercalators containing the 
ruthenium (II) tris(1-pyrazolyl)methane Unit. 
Four new polypyridyl ruthenium (II) complexes containing a linker group, [Ru(tpm)(dppz)(µ-
L1)](PF6)2 [1],[Ru(tpm)(dppz)(µ-L2)](PF6)2 [2], [{Ru(tpm)(dppz)}2(µ-L1)](PF6)4 [3] and 
[{Ru(tpm)(dppz)}2(µ-L2)](PF6)4 [4], and their DNA binding properties have been 
established. The combination of viscometry, fluorescence and absorption spectroscopy data 
show that these complexes bind to DNA, most likely through intercalation. Complexes [1] 
and [3] seem to intercalate more strongly than complexes [2] and [4]. It seems the more rigid 
linker group may restrict full insertion of intercalative sites between the DNA base pairs. For 
the more flexible linker, the complex can sit more comfortably within the minor groove 
resulting in enhanced the binding compared. Whatever the reason, it is clear that the binding 
affinity of these complexes towards DNA is affected by the nature of the functional group in 
a linker.   
To further investigate the properties of these complexes with DNA, isothermal titration 
calorimetry (ITC) was used as this can provide a complete thermodynamic profile on the 




6.2 Chapter 3: The effect of the nature and positioning of the functional 
group on the binding mode and affinity of Ruthenium polypyridyl 
complexes. 
In this chapter, the synthesis and characterization by UV-visible spectroscopy, luminescence 
titrations, 
l
H NMR and mass spectrometry of four new ruthenium complexes, 
[Ru(tpm)(dppz)(µ-L'1)](PF6)2 [5], [Ru(tpm)(dppz)(µ-L'2)](PF6)2 [6], [{Ru(tpm)(dppz)}2(µ-
L'1)](PF6)4 [7] and [{Ru(tpm)(dppz)}2(µ-L'2)](PF6)4 [8],  have been investigated and their 
binding with CT-DNA has been studied. Absorption titrations showed ~10nm bathochromic 




Viscosity measurements confirmed that the complex-DNA interaction is through 
intercalation. These results confirm that both mono and di complexes are avid binders of CT 
DNA and that the dipyridophenazine ligand on them is engaged in the intercalative 
interaction with DNA.  
Furthermore, in comparison with complexes [1-4] the interactions of complexes [5-8] with 
DNA are stronger. Or particular note is the fact that the dinuclear complexes show enhanced 
binding compared to their mononuclear analogues. Indeed, the viscosity measurement present 
clear evidence that [8]Cl4 is in fact a bis-intercalator. The results described in this study 
highlight how the nature and positioning of functional groups within the complexes affect 
binding affinities. Results from the isothermal titration calorimetry for complexes [1-4] and 
[5-8] are discussed in chapter 4. 
 
 
6.3 Chapter 4: Isothermal Titration Calorimetry (ITC). 
The ITC evidence has been used to obtain complete thermodynamic profiles (∆G°, ∆H°, ∆S°) 
for the interaction of both sets of complexes [1-4] and [5-8] with CT-DNA. The results show 
the binding of these complexes are generally entropically favoured. The binding affinities of 
these complexes suggest that complexes [5-8] interactively bind to CT-DNA more strongly 
than complexes [1-4]. Moreover, both ITC and spectroscopic studies show a significant 
increase in binding affinity for DNA for the monometallic and bimetallic complexes [5-8] 
containing 3-Py positioned tethers. These results have confirmed that the positioning of the 
functional group can have a profound effect on the binding affinities of these complexes. 
 
 






The new hetero-dinuclear dppz complex is reported. The interaction of complex [9] with 
double-stranded calf thymus DNA has been studied by absorption and emission titrations. 




switch effect but not DNA cleavage properties. The thermodynamic parameters showed that 
the complex-DNA interaction is enthalpically unfavourable and entropically favoured. 
Moreover, although the molecule does not display significant phototoxicity, with a PI of 2, it 
displays significant dark cytotoxicity.  
 
 




 Polypyridyl complex with mixed-bis-
intercalating ligands (dppz-dppn). 
In this section, mono and dinuclear ruthenium complexes containing a longer intercalative 
motif dppn, as well as a dinuclear ruthenium system with mixed-bis-intercalating ligands 
(dppz-dppn), have been synthesized.  The DNA binding properties of these complexes have 
been investigated. It was found that the mono and dinuclear complexes [10] and [11] bound 
to DNA with affinities that are at the same order of magnitude or lower with respect to their 
analogous dppz complexes. However, hetero-intercalators complex [12] had the largest 
binding constant observed for any of the dinuclear systems synthesized in our group. 
Complexes [10] and [11] do not display 
3
MLCT based luminescence in both acetonitrile and 
water. However, complex [12] does display a change in emission spectrum around ̴ 640 nm 
upon addition of CT-DNA. The 
1
O2 quantum yields of these systems revealed that complex 
[11] has a higher quantum yield value compared to complex [12]. Furthermore, the DNA 
photocleavage properties of [10] and [11] were investigated. The results showed that in the 
presence of [10] and [11], the supercoiled native form (I) completely disappears. This 
appears to be because both [10] and [11] complexes cleave the DNA strands into very small, 
fast moving fragments. All three complexes have high phototoxicity indices against both cell 
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7.0 Experimental   
7.1 Materials and Equipment  
7.1.1 Chemicals  
 
All chemicals and solvents were purchased from commercial sources and were used as 
supplied unless otherwise stated.  
 
 




H NMR spectra were carried out on a Bruker AV2-400 machine, working in 
Fourier transform mode.  
More complex 
1
H NMR experiments were performed by Sue Bradshaw of the University of 
Sheffield. The spectra were recorded on a Bruker DRX500 machine.  
The following abbreviations are used in the annotation of 
1
H spectra; s - singlet, d - doublet, 
dd - double doublet, dt - double triplet, t - triplet, q - quartet and m - multiplet.  
 
 
7.1.3 Mass Spectrometry  
 
ES mass spectra were recorded on a Micromass LCT ES-TOF machine. All spectra were run 






7.1.4 UV-Visible Absorption Spectroscopy 
   
All UV-Visible spectra were recorded on a thermo regulated Varian-Carey 50 UV-Visible 




corrected using Cary Win UV software and were diluted accordingly to give readings 
between 0.0 and 1.0 absorbance units. 
 
 
7.1.5 Luminescence Spectroscopy  
Luminescence spectra were recorded on a thermo regulated Horiba Jobin-Yvon FluoroMax-3 
spectrophotometer operating in luminescence wavelength scan mode at 25°C, with excitation 
and emission slit widths at 5 nm. 
                
      
7.2 DNA Binding Studies 
7.2.1 Buffer Preparation 
Tris buffer (pH 7.4) was prepared using Trizma HCl (Tris(hydroxymethyl)aminomethane) 
base at 5 mM concentrations in 25 mM NaCl. Trizma HCl and NaCl were measured into a 
volumetric flask and dissolved in deionised water (Millipore HPLC grade). The pH was 
adjusting using dilute HCl and additional water added to achieve the correct volume. Buffer 
solutions were passed through 0.2 micron Millipore filters and autoclaved for 4 hours. The 
subsequent sterile solution was refrigerated at 4C.                                                                     
                      
7.2.2 Sample Preparation 
All ruthenium complexes were converted into their water soluble chloride derivatives prior to 
biological testing. This was done by dissolving the hexafluorophosphate salt of each complex 
in the minimum volume of acetone and a saturated solution of ammonium chloride in acetone 
added. The resultant precipitated chloride salt was collected by filtration, washed with 
acetone and dried in vacuo.                                                                                                           





7.2.3 DNA Preparation 
Calf Thymus DNA (CT-DNA) was purchased from Sigma-Chemicals as the lyophilised solid 
sodium salt and used without further purification. DNA length was averaged to 200-300 base 
pairs by dissolving ~100 mgs of the solid material in 20 ml of tris buffer (5 mM Tris, 25 mM 
NaCl) and leaving refrigerated overnight and then subjecting samples to discontinuous 
sonication using a Sonics Vibra-Cell VCX130, fitted with a 19 mm diameter probe. DNA 
samples were quantified in terms of quality and concentration by conventional absorbance 
measurements.
1 
Nucleic acids have an absorbance maximum at 260 nm and contaminants 
such as proteins and single stranded DNA/RNA absorb maximally at 280 nm. The purity of a 
sample is measured by calculating the ratio of contaminants to DNA, with A260/A280 > 1.9 
indicating a protein free sample (in reality anything over 1.8 is acceptable for a cuvette 
sample in a spectrometer). The concentration of the resulting solutions was also determined 




 for CT-DNA.           
                                                                                                                                       
                                                                                                               
7.2.4 Viscometry  
Viscosity experiments were carried out in a 1 ml Cannon-Manning semi-micro viscometer 
(size 50) immersed in a thermostated water bath. The temperature was maintained at 26 ± 1 
°C. The concentration of CT-DNA in the viscometer was kept at ~ 50 µM bp
-1
. Additions of 
the analyte were made so that the values of 1/R (R = [DNA]/[ligand]) were between 0 and 
0.3.                                                                                                                                                 
 Buffer solutions were allowed to stand in the viscometer for 45 minutes before readings were 
taken. After the addition of CT-DNA the solution were left to equilibrate for 20 minutes. 
After each addition of the analyte to the system an equilibrium time of 20 minutes was 
allowed before the flow times were recorded. After each addition the solution was drawn 
through the viscometer and mixed under vacuum 5 times before being left to equilibrate in 
order to ensure the solution was homogenous. Times were recorded in triplicate and the 






7.2.5 UV-Visible Titrations 
UV-Visible titrations were performed on a thermo regulated Varian-Carey 50 UV-Visible 
spectrometer at 25°C. 1 ml of buffer was loaded into a 10 mm path length cuvette and 
allowed to equilibrate inside the spectrometer before a baseline reading was taken. A volume 
of buffer was removed with a Gilson pipette and replaced with the same volume of a stock 
solution of complex to give a final concentration of around 10-15 μM complex inside the 
cuvette. After equilibration the spectrum was recorded between 200-600 nm. 2.5 μL of a 
concentrated stock solution of CT-DNA was added to the cuvette and mixed 10 times with a 
pipette to ensure homogeneity. The spectrum was recorded after leaving the sample to 
equilibrate for 5 minutes, checking no bubbles were present. This procedure was continued 
until the absorbance became constant indicating saturation binding had occurred or the 
increase of CT-DNA concentration only caused small changes in the absorption spectra.    
                                                                                                                                                                     
7.2.6 Luminescence Titrations 
Luminescence titrations were carried out in a thermo regulated Horiba Jobin-Yvon 
FluoroMax-3 spectrophotometer in a procedure similar to the UV-Visible titrations.  3 mL of 
buffer was loaded into 10 mm path length luminescence cuvette and allowed to equilibrate 
inside the spectrophotometer at 25°C before a background reading was taken. A volume of 
buffer was removed and replaced with the same volume of a stock solution of complex to 
give a final concentration of around 15 μM complex inside the cuvette. After equilibration, 
the emission spectrum of the solution was recorded using the excitation wavelength 
characteristic of the complex. 2.5 μL of a concentrated stock solution of CT-DNA was added 
to the cuvette and mixed 10 times to ensure homogeneity. After leaving the sample to 
equilibrate for 3 minutes and checking no bubbles were present, the emission spectrum was 
recorded, showing an enhancement in emission. The procedure was continued until the 
emission became constant.     
     
7.2.7 Isothermal Titration Calorimetry  
Calorimetric data was obtained in Cardiff University, using a MicroCalorimeter. During 




DNA (0.25 mM in tris buffer). Aliquots of the interacting complex (1 mM) were then titrated 
into the DNA solution, which was stirred continuously at 301 rpm and maintained at 25 °C 
unless is specified. Initial injection of 5 μl was made to remove error followed by 15 μl 
throughout the rest of the experiment. Heats of dilution for each compound were determined 
by titrating the complex into buffer solution. These dilution heats were subtracted from the 
ΔH value for DNA-complex titrations to give a corrected heat effect. Each titration was 




7.2.8 Agarose Gel Electrophoresis of DNA  
Photoinduced cleavage of supercoiled pBR322 and pUC57 DNA by the complexes was 
studied by agarose gel electrophoresis. The reactions were performed under illuminated 
conditions using 470 nm using FLUOstar OPTIMA microplate reader. The sample was 
prepared in a dark room at room temperature using supercoiled DNA (0.1 μg/μL) in 50 mM 
Tris-HCL buffer and varying concentrations of the complex. After photoexposure, the sample 
was incubated followed by the addition of the loading buffer containing 25% bromophenol 
blue, 0.25% xylene cyanol and 30 % glycerol (2 µL), and the solution was finally loaded on 
an 0.8% agarose gel containing 1.0 µg/mL ethidium bromide. Electrophoresis was carried out 
for an hour at 100 mW in TAE (Tris-acetate-EDTA) buffer. The gel was visualised using a 
UVP transilluminator and photographed for analysis.   
 
 
7.2.9 Transient Absorption Spectroscopy  
Picosecond transient absorption experiments were performed on a home-built pump-probe 
setup. The fundamental output (~ 3 mJ, 20 ps, 10 Hz, 1064 nm) of a ps mode-locked 
Nd:YAG laser PL2251 (EKSPLA) was passed through a computer-controlled optical delay 
line (made of IMS600 linear stage from NEWPORT; 60 cm travel range), and focused with a 
0.5 m lens into a 10 cm cell with D2O to generate a picosecond super-continuum, which 
served as a probe beam. The broadband super-continuum beam was split with a beam splitter 




passed through the sample one above the other, each focused into a ~ 0.5mm spot on the 
sample. Afterwards the signal and reference beams were focused with an achromatic 
condenser onto the entrance slit of the spectrograph (a Hilger & Watts 30 cm monochromator 
home-converted into a spectrograph by replacing the grating, exit flat mirror, removing exit 
slit, and fitting a CCD mounting adaptor). Both signal and reference beams were detected 
with a CCD camera (ANDOR iDus, DV420A) operated in the dual-track mode. The 
at the sample. The pump and the signal probe beams were overlapped at the sample at small 
angle. The instrumental response function duration of the setup is estimated to be ca. 27 ps. 
The operation of the setup and the data acquisition process are controlled by custom-




7.3 Cellular phototoxicity Studies 
7.3.1 Light Irradiation Source Apparatus (LISA) 
The apparatus used to irradiate the samples was a custom made device featuring a broadband 
illumination source fully contained in an empty computer base unit, referred to as the Light 
Irradiation Source Apparatus (LISA). The technical specifications of the bulb contained 
within are as follows (Table 1). 
 
Product Code 871691 
International Model Number HC01080i 
Description CFL 80W E40 Integrated Clusterlite 
4000K Watts 80W 
Cap E40 
Operating Hours 15000 
Colour Temp 4000K 
Lumens 5400 lm 
Dimming No 
Dimensions (length x diameter) 256mm x 80mm 
 




7.3.2 Photocytotoxicity (phototoxicity) 
Cells were maintained in RPMI 1640 medium supplemented with 10% FBS, 100 mg ml
-1
 
streptomycin, 100 units ml
-1
 penicillin, and 2 mM glutamine at 37°C in a humidified 
atmosphere containing 5% CO2. Experimental cultures were grown on 48 well plates at a 
seeding density of 5 x 10
4
 cells per well and incubated for 24 h. The cells were then treated 
with complex (solubilised in and maintained at 10% PBS/H2O: 90% medium throughout all 
solutions) of a 1 – 100 μM concentration range, in triplicate, and incubated for 24 h. All 
complex solution (and control medium) was removed from the cells and replaced with 
regular growth medium 30 min prior to irradiation. Of the four prepared well plates, one 
remained in the incubator whilst the other three were exposed to the LISA for the duration of 
5, 15 or 30 min (corresponding to light doses of 8, 24 or 48 J cm
-2
) before being incubated for 
a further 24 h after culmination of light treatment. All medium was then removed and cells 
incubated with MTT (0.5 mg ml
-1
 dissolved in PBS) for 30 – 40 min. The MTT was removed 
and formazan product eluted using 120 µl/well acidified isopropanol, 100 µl of which was 
transferred to a 96 well plate for the absorbance to be quantified by spectrophotometer (540 
nm, referenced at 640 nm). An average absorbance for each concentration was calculated and 
cell viability was determined as a percentage of the untreated negative control wells (10% 
PBS/H2O: 90% medium, average of triplicate). Data were plotted in a graph of concentration 
against cell viability to produce a curve from which the IC50 value could be derived by 
interpolation. 
 
7.3.3 Intracellular metal content (ICP-MS) 
Cell cultures were grown on 60 mm dishes at a seeding density of 5 x10
5
 cells per dish and 
incubated for 24 h. Cells were then treated with the complex (solubilised in and maintained at 
10% PBS/H2O: 90% medium throughout all solutions) at the stated concentration and 
incubated for 24 h. All complex solution (or control medium) was removed, cells washed 
with PBS and 1 ml of both serum-free medium and trypsin solution added. Dishes were 
incubated for 3 min and shaken to remove cells (plus scraped to detach any remaining cells) 
which were transferred to microcentrifuge tubes and centrifuged (4000 rpm, 3 min). The 
supernatant was removed, pellet resuspended in 500 µl serum-free medium and cells counted. 




to 60°C overnight and then diluted to 10 ml total volume with ultrapure Milli-Q H2O before 
analysis of ruthenium content by inductively coupled plasma mass spectrometry (ICP-MS). 
Using the obtained ruthenium concentration, the sample volume, number of cells per sample 
and the assumption of a cell volume of 2 x10
-12 
L an estimate of intracellular concentration 
(mol L
-1





























This compound was prepared following a previously reported procedure. A three neck round 
bottom flask equipped with a reflux condenser and a mechanical overhead stirrer was placed 
in an oil bath on a stirrer hot plate. Pyrazole (40.0 g, 0.59 mol) and tetra-n-
butylammoniumbromide (9.4 g, 29.27 mmol) were added to the flask followed by distilled 
water (500 ml) with vigorous stirring, sodium carbonate (400 g, 3.78 mol) was added 
gradually to the reaction mixture, constant stirring increase the efficiency of the reaction. 
After cooling to near room temperature, chloroform (250 ml) was added and the mixture 
heated at gentle reflux for 3 days with rapid stirring, after which time the organic layer had 
turned dark yellow in colour the mixture was allowed to cool to room temperature and 
filtrate. The organic layer was separated and the aqueous layer extracted with 
dichloromethane (3 x 300 ml). The combined organic layers were then washed with saturated 
brine solution (500 ml) and dried over magnesium sulphate. Filtration and concentration of 
the filtrate under reduced pressure yielded a yellow coloured solid. The crude product can be 
purified by a recrystallization from water and dried under vacuum.  
 
Mass (Yield): 24.92 g (60%). 






H NMR (400 MHz, CDCl3): δH = 8.74 (s, 1H), 7.87 (d, J = 1.4 Hz, 3H), 7.63 (d, J = 2.5 Hz, 










This compound was prepared following a previously reported procedure. 1,10-phenanthroline 
(5.40 g, 30 mmol) was added into a solution of 60% sulphuric acid (70 ml). After the solid 
compound was dissolved, potassium bromate (5.510 g, 32 mmol) was added over a period of 
half an hour. The mixture was stirred at room temperature for 20h. Then, the mixture was 
poured over ice and was carefully neutralized to pH 7 using a saturated solution of sodium 
hydroxide. The solution was then filtered, extracted with CH2Cl2 and evaporated to dryness. 
The crude product was recrystallised from methanol to provide the desired product in 80-
90%.                                                                                                           
                                                                                                           
Mass (Yield): 4.59 g (85%). 




H NMR (400 MHz, CDCl3): δH = 8.45 (dd, J = 4.7 Hz, 1.8 Hz, 2H), 7.98 (dd, J = 7.9 Hz, 












7.4.3 Preparation of dipyrido [3,2-a:2ꞌ,3ꞌ-c] Phenazine (DPPZ)
4
 
                                         
 
 
This compound was prepared following a previously reported procedure. 1,10-
phenanthroline-5,6-dione (2.0 g, 9.51 mmol) and o-phenylene diamine (1.02 g, 9.43 mmol) 
were refluxed in ethanol (100 ml)  for 2 hours, (solution turned from dark brown to deep red). 
After cooling the solvent was removed in vacuo and the resulting solid was recrystallized 
with 1:1 ethanol/water. The recrystallized orange needles were collected by filtration, washed 
subsequently with ice cold water (30 ml) and ethanol (50 ml) and dried in vacuo.
4
                                                                                                                                           
                                                                                    
Mass (Yield): 1.11 g (58%). 




H NMR (250 MHz, CDCl3): δH = 9.67 (dd, J = 8.1, 1.8 Hz, 2H), 9.30 (dd, J = 4.5, 1.8 Hz, 










A solution of 4-pyridinecarboxaldehyde (18.5 g, 173 mmol) in ethanol (100 mL) was added 
to a solution of 1,6-hexanediamine (10.0 g, 86.6 mmol) in ethanol (200 mL) and then heated 
to reflux for 2 h. The reaction solution was allowed to cool to room temperature. NaBH4 (8.0 
g, 211 mmol) was carefully added in small portions and the mixture was heated to reflux for 
2 h and then stirred at room temperature overnight. Aqueous NaOH (2.0 M, 200 mL) was 
added to the solution. The aqueous solution was extracted with CH2Cl2 (3 × 200 mL), the 
organic fractions combined and dried over anhydrous MgSO4. Filtration and concentration 
under reduced pressure yielded pale coloured viscous oil. On shaking with diethyl ether a 
cream coloured solid precipitated, which was collected by filtration, washed with copious 
amounts of diethyl ether and dried in vacuo. 
 
Mass (Yield): 20.2 g (74%). 




H NMR (400 MHz, CDCl3): δH  =  8.49 (dd, J = 8.0, 2.8 Hz, 4H), 7.50 (d, J = 8.0 Hz, 4H), 










Benzene-1,4-dicarboxaldehyde (5.0 g, 27.3 mmol) and 4-(aminomethyl)pyridine (8.06 g, 74.6 
mmol) were placed in CH2Cl2 (100 mL). Anhydrous MgSO4 (20 g) was added to the solution 
and the mixture was stirred at room temperature for 24 h. The mixture was filtered and the 




viscous oil which was not isolated. The oil was taken up in ethanol (150 mL), NaBH4 (4.0 g, 
106 mmol) was added in small portions and then the mixture was heated to reflux for 2 h and 
then stirred at room temperature overnight. Aqueous NaOH (2.0 M, 200 mL) was added to 
the solution. The aqueous solution was extracted with CH2Cl2 (3×100 mL), the organic 
fractions combined and dried over anhydrous MgSO4. Filtration and concentration under 
reduced pressure yielded the product as golden coloured viscous oil which solidified into a 
waxy solid. 
 
Mass (Yield): 9.5 g (80%). 




H NMR (400 MHz, CDCl3): δH  = 8.47 (dd, J = 6.2, 2.8 Hz, 4H), 7.28–7.22 (m,8H), 3.78 (s, 
4H), 3.72 (s, 4H).  
 




Tris (1-pyrazolyl) methane (0.861 g, 4.02 mmol) and RuCl3.3H2O (1.051 g, 4.01 mmol) were 
refluxed in ethanol (200 ml) for three hours. After cooling, the dark precipitate was filtered 
and washed with cold ethanol (5 ml) and diethyl ether (5 ml) and then dried under vacuum.    
  
Mass (Yield): 1.27 g (62%). 







H NMR (400 MHz, CDCl3): δH = 8.87 (s, 1H), 8.52 (d, J = 6.4 Hz, 3H), 8.11 (d, J = 6.5 Hz, 
3H), 6.65 (m, 3H). 
 




(tpm)RuCl3.3H2O (0.6 g, 1.42 mmol), dppz (1.1 eq, 0.44g, 1.57 mmol) and LiCl (0.48 g, 
0.011 mmol) were heated to reflux in 3:1 ethanol: water (100ml) for 10mins. 12 drops of 
triethylamine were added and refluxing continued for 3 hours. After cooling the solvent was 
removed and the black residue was dissolved in methanol (25 ml) and a fine black solid was 
filtered out. The product was precipitated by addition of aqueous NH4PF6 and collected by 
filtration. The crude product was chromatographed on grade one alumina with 1:1 toluene: 
acetonitrile. The deep brown band was collected and concentrated. Addition of Et2O 
precipitated the product as a deep brown solid.                                                                                                                   
                                                                                                                 
Mass (Yield): 0.35 g (42%). 




H NMR (400 MHz, d6-acetone): δH = 9.71 (dd, J = 8.1 Hz, 1.2 Hz, 2H), 9.40 (dd, J = 5.4 
Hz, 1.2 Hz, 2H), 8.74 (s, 1H), 8.57 (d, J = 2.9 Hz, 2H), 8.43 (d, J = 2.1 Hz, 2H), 8.40 (dd, J = 
6.6 Hz, 3.4 Hz, 2H), 8.19 (d, J = 2.7 Hz, 1H), 8.12 (dd, J = 6.6 Hz, 3.4 Hz, 2H), 7.1 (dd, J = 





       




[tpmRuCldppz]Cl (0.213 g, 0.31 mmol) and AgNO3 (2.1eq, 0.107 g, 0.62 mmol) were 
refluxed in 1:1 EtOH / H2O (100 ml) under nitrogen for 3 hours. The solution was cooled and 
filtered through celite to remove AgCl. The filtrate was returned to the flask along with 
L1(dph) ligand (10 eq, 0.946 g, 3.1 mmol ) and the mixture was refluxed for 10 hours. After 
cooling the solution was concentrated and NH4PF6 was added until the complex precipitated. 
After collection by filtration the crude product was dissolved in acetone (10 ml). Bu4NCl was 
added to precipitate the product as a chloride salt which was collected by filtration and 
copiously washed with acetone to remove excess µ-L1. The red solid was dried in vacuo.                                                                                                
 A small amount of the product was converted to its PF6 ̄ salt for analysis.       
Mass (Yield): 0.23 g (75%). 




H NMR (250 MHz, d6-acetone):  δH = 9.84 (d, J = 8.2 Hz, 2H), 9.17 – 9.03 (m, 2H), 8.76 
(s, 1H), 8.51 (m, 2H), 8.37 (t, J = 11.3 Hz, 2H), 8.23 (dd, J = 6.5, 3.4 Hz, 2H), 8.07 (dd, J = 




2.1 Hz, 1H), 6.33 – 6.16 (m, 2H), 4.14 (s, 2H), 4.05 (s, 2H), 2.99 (t, J = 10 Hz, 2H), 2.94 (t, J 
= 5 Hz, 2H), 1.93 (m, 4H), 1.59(m, 4H). 
 
  




This complex was prepared in an identical manner to the previous complex except replacing 
ligand L1 with L2. 
A small amount of the product was converted to its PF6 ̄ salt for analysis.  
                                                                                          
Mass (Yield): 0.172 g (56%). 




H NMR (250 MHz, d6-acetone): δH  = 9.84 (d, J = 7.1 Hz, 2H), 9.02 (dd, J = 6.6, 3.3 Hz, 
2H), 8.86 (s, 1H), 8.74 – 8.50 (m, 4H), 8.50 – 8.35 (m, 4H), 8.23 (dd, J = 6.5, 3.4 Hz, 4H), 
8.12 – 7.94 (m, 2H), 7.73 (dd, J = 3.7, 7.0 Hz, 4H), 7.60 (s, 4H), 7.58 – 7.31 (m, 4H), 6.84 (d, 










[(tpm)Ru(dppz)(Cl)]Cl (65 mg, 0.096 mmol) and AgNO3 (2.1eq, 34.5 mg, 0.2 mmol) were 
placed in a 1:1 mixture of ethanol and water (40 mL) and heated to reflux for 2 hours. The 
solution was allowed to cool and filtered through celite to remove the AgCl precipitate. The 
filtrate was returned to the reaction vessel. [(tpm)Ru(dppz)(L1)][(PF6)2] (360 mg, 0.3 mmol) 
in acetone (15 mL) was added and the solution reflux for 72 h. The solution was allowed to 
cool to room temperature. Purification was achieved via ion-exchange chromatography on 
Sephadex CM-25 resin eluting with water: acetone mixtures (5:3) with increasing 
concentrations of NaCl. Monomeric complexes were eluted with 0.05 M NaCl and the 
desired bimetallic complex was eluted with 0.1–0.2 M NaCl in water: acetone (5:3). A 
concentrated aqueous solution of NH4PF6 (~10 mL) was added to the filtrate. On 
concentration in vacuo, the bimetallic complex precipitated. It was collected by 
centrifugation, washed with copious amounts of water and dried in vacuo. 
 
 
Mass (Yield): 0.201 g (48%). 







H NMR (400 MHz, d6-acetone): δH  = 10.09 (s, 2H), 9.83 (dd, J = 3.0, 2.3,Hz, 4H), 9.11 
(dd, J = 1.3, 5.8 Hz, 4H), 8.97 (d, J = 2.4 Hz, 2H), 8.77 – 8.49 (m, 4H), 8.38 (dd, J = 4.1, 2.9 
Hz, 4H), 8.38 – 8.10 (m, 4H), 8.10 – 7.97 (m, 4H), 7.66 – 7.42 (m, 6H), 7.09 (t, J = 6.3 Hz, 
2H), 6.96 – 6.75 (m, 4H), 6.64 (d, J = 2.3 Hz, 2H), 6.34 – 6.21 (m, 2H), 4.28 (s, 4H), 3.38 










This complex was prepared in an identical manner to that above, except replacing the   
monomeric complex [(tpm)Ru(dppz)(L1)][(PF6)2] with [(tpm)Ru(dppz)(L2)][(PF6)2].         
 
Mass (Yield): 0.189 g (45%). 




H NMR ( 400 MHz, d6-acetone): δH = 9.96 (s, 2H), 9.90 – 9.74 (m, 4H), 9.64 (d, J = 8.1 




J = 4.0 Hz, 4H), 8.19 – 7.99 (m, 4H), 7.68 (d, J = 3.3 Hz, 4H), 7.44 (t, J = 2.1 Hz, 4H), 7.13 
(d, J = 5.8 Hz, 4H), 7.13 – 6.92 (m, 4H), 6.87 – 6.57 (m, 4H), 6.57 – 6.37 (m, 2H), 6.19 (t, J = 









A solution of 3-pyridinecarboxaldehyde (18.5 g, 173 mmol) in ethanol (100 mL) was added 
to a solution of 1,6-hexanediamine (10.0 g, 86.6 mmol) in ethanol (200 mL) and then heated 
to reflux for 2 h. The reaction solution was allowed to cool to room temperature. NaBH4 (8.0 
g, 211 mmol) was carefully added in small portions and then the mixture was heated to reflux 
for 2 h and then stirred at room temperature overnight. Aqueous NaOH (2.0 M, 200 mL) was 
added to the solution. The aqueous solution was extracted with CH2Cl2 (3 × 200 mL), the 
organic fractions combined and dried over anhydrous MgSO4. Filtration and concentration 
under reduced pressure yielded a cream coloured viscous oil product. 
 
 
Mass (Yield): 15.72 g (84.9 %). 




H NMR (400 MHz, CDCl3): δH
 
= 8.49 (s, 2H), 8.33 (d, J = 6.0 Hz, 2H), 7.38 (m, 2H), 6.99 













Benzene-1,4-dicarboxaldehyde (5.0 g, 27.3 mmol) and 3-(aminomethyl)pyridine (8.06 g, 74.6 
mmol) were placed in CH2Cl2 (100 mL). Anhydrous MgSO4 (20 g) was added to the solution 
and the mixture was stirred at room temperature for 24 h. The mixture was filtered and the 
filtrate concentrated under reduced pressure yielding the Schiff base as golden coloured 
viscous oil which was not isolated. The oil was taken up in ethanol (150 mL), NaBH4 (4.0 g, 
106 mmol) was added in small portions and then the mixture was heated to reflux for 2 h and 
then stirred at room temperature overnight. Aqueous NaOH (2.0 M, 200 mL) was added to 
the solution. The aqueous solution was extracted with CH2Cl2 (3×100 mL), the organic 
fractions combined and dried over anhydrous MgSO4. Filtration and concentration under 
reduced pressure yielded the product as golden coloured viscous oil. 
 
Mass (Yield): 4.01 g (80%). 




H NMR (400 MHz, CDCl3): δH
 
= 8.52 (s, 2H), 8.35 (d, J = 6.0 Hz, 2H), 7.76 (d, J = 8.0 Hz 











7.4.14 Preparation of [(tpm)Ru(dppz)(µ-L’1)][Cl2] 
 
 
This complex was prepared in an analogous way to (7.4.8) except using L'1 ligand instead of 
L1 ligand. 
 
Mass (Yield): 0.095 g (63.3 %). 




H NMR (400 MHz, CD3CN): δH = 10.06 (s, 1H), 9.81 (d, J = 8.2 Hz, 2H), 9.10 (d, J = 5.5 
Hz, 2H), 8.67 (d, J = 5.3 Hz, 2H), 8.48 (d, J = 2.8 Hz, 2H), 8.20 (m, 2H), 7.87 (m, 2H), 7.82 
(m, 2H), 7.48 (dd, J = 10 Hz, 4 Hz, 2H), 7.38 (m, 2H), 7.06 (dd, J = 4.4, 1.4 Hz, 2H), 6.83 (t, 
J = 4 Hz, 2H). 6.79 (m, 2H), 6.44 (d, J = 2.2 Hz, 2H), 6.29 – 6.14 (m, 1H), 4.34 (s, 2H), 3.53 












This complex was prepared in an analogous way to (7.4.9) except using L'2 ligand instead of 
L2 ligand. 
 
Mass (Yield): 0.065 g (65%). 




H NMR (400 MHz, CD3CN): δH =  9.81 (d, J = 7.6 Hz, 2H), 9.13 (s,1H), 9.08 (d, J = 4.7 
Hz, 2H), 8.63  (t, J = 7.8 Hz, 2H), 8.60 (d, J = 2.4 Hz, 2H), 8.57 (m, 2H), 8.41 (d, J = 2.5 Hz, 
2H), 8.21 (m, 2H), 8.06 (d, J = 2.8 Hz, 2H), 7.85 (d, J = 8 Hz, 2H), 7.56 (m, 4H), 7.36 (d, J = 
6 Hz, 2H), 7.05 (t, J = 8 Hz, 2H), 6.80 (t, J = 2.3 Hz, 2H), 6.38 (d, J = 2.0 Hz, 2H), 6.17 (t, J 












This complex was prepared in an analogous way to (7.4.10) except using 
[{(tpm)Ru(dppz)}(µ-L’1)][(PF6)2] instead of [{(tpm)Ru(dppz)}(µ-L1)][(PF6)2]. 
 
 
Mass (Yield): 0.060 g (60%). 




H NMR (400 MHz, CD3CN): δH =  9.83 (dd, J = 8.2, 1.2 Hz, 4H), 9.21 (s, 2H), 9.10 (d, J = 
5.6 Hz, 2H), 8.38 (d, J = 2.8 Hz, 4H), 8.27 (m, 6H), 8.12 (s, 2H), 8.02 (m, 2H), 7.81 (dd, J = 
9.9, 4.2 Hz, 8H), 7.67 (dd, J = 7.8, 6.0 Hz, 4H), 7.50 (m, 4H), 7.25 (t, J = 1.6 Hz, 2H), 6.86 (t, 













This complex was prepared in an analogous way to (7.4.11) except using 
[{(tpm)Ru(dppz)}(µ-L’2)][(PF6)2] instead of [{(tpm)Ru(dppz)}(µ-L2)][(PF6)2]. 
 
Mass (Yield): 0.073 g (56 %). 




H NMR (400 MHz, CD3CN): δH =  9.79 (dd, J = 7.9, 2.5 Hz, 4H), 9.21 (m, 2H), 9.10 (s, 
2H), 8.64 (m, 4H), 8.53 (t, J = 4.9 Hz, 4H), 8.36 (t, J = 4.9 Hz, 4H), 8.20 (s, 2H), 8.17 (m, 
2H), 7.96 (m, 4H), 7.80 (m, 4H), 7.62 (d, J = 2.3 Hz, 4H), 7.28 (m, 2H), 7.08 (s, 4H), 6.81 















Re(CO)5Cl (150 mg, 0.410 mmol) and dppz (130 mg, 0.460 mmol) were refluxed in toluene 
(50 ml) for 6 hours. After cooling to room temperature a yellow precipitate formed which 
was collected by filtration, washed with toluene (25 ml) and Et2O (25 ml) and dried in vacuo. 
 
Mass (Yield): 0.135 g (90 %). 
TOF MS ES+, m/z: 588 (15) [M
+
], 560 (90) [M
+





H NMR (400 MHz, CDCl3): δH = 9.90 (dd, J = 8.2, 1.4 Hz, 2H), 9.49(dd, J = 5.2, 1.4 Hz, 























[Re(CO)3Cldppz] (80 mg, 0.131 mmol) and AgCF3SO3 (2.1eq, 45 mg, 0.175 mmol) were 
placed in ethanol (50 mL) and heated to reflux overnight. The solution was allowed to cool 
and filtered through celite to remove the AgCl precipitate. The yellow coloured filtrate was 
returned to the reaction vessel. [(tpm)Ru(dppz)(L1)]Cl2 (40 mg, 0.041 mmol) was added and 
the solution was refluxed overnight again. The solution was allowed to cool to room 
temperature and then evaporated to get a red-brown precipitate.   
 
Mass (Yield): 0.030 g (37.5 %). 




H NMR (400 MHz, D2O): δH = 9.79 (s, 1H), 9.59 (d, J = 9.0 Hz, 4H), 9.02 (d, J = 5.3 Hz, 
4H), 8.55 (d, 4H), 8.20 (m, J = 2.8 Hz, 4H), 8.08  (m, 4H), 7.85 (dd, J = 8.2, 5.4 Hz, 4H), 
7.50 (d, J = 6.2 Hz, 4H), 7.31 (d, J = 5.9 Hz, 4H), 6.92 (d, J = 5.9 Hz, 2H), 6.70 (m, 2H), 6.24 












This compound was prepared following a previously reported procedure. 1,10-
phenanthroline-5,6-dione (300 mg, 4.76 mmol) and 2,3-diaminonaphthalene (252 mg, 1.59 
mmol) were suspended in methanol (60 ml) and heated under reflux for 1 h, during which 
time a bright-orange coloured precipitate formed. The precipitate was collected, washed 




Mass (Yield): 0.273 g (91%). 




H NMR (400 MHz, CDCl3): δH =9.56 (dd, J = 8.1, 1.7 Hz, 2H), 9.25 (dd, J = 4.4, 1.7 Hz, 
2H), 8.86 (s, 2H), 8.16 (dd, J = 6.5, 3.2 Hz, 2H), 7.76 (dd, J = 8.1, 4.5 Hz, 2H), 7.68 (dd, J = 


















(tpm)RuCl3.3H2O (125 mg, 0.262 mmol) and dppn (95 mg, 0.286 mmol) were heated to 
reflux in ethylene glycol (50 ml) at 120 ºC for 18 hours. The solution was allowed to cool, 
poured into methanol (100 ml), and filtered through celite. An excess of aqueous NH4PF6 was 
added to the solution, causing precipitation of brown coloured solid which was collected with 
copious amount of water, diethyl ether and dried in vacuo to give a dark-brown coloured 
solid. The crude product was purified via chromatography through neutral alumina, using 
acetonitrile:toluene [50:50, V/V] as eluent. The desired brown coloured band containing the 
product were collected and concentrated then dries in vacuo.  
 
 
Mass (Yield): 0.087 g (70 %). 




H NMR (400 MHz, CD3CN): δH  = 9.77 (dd, J = 8.0, 1.2 Hz, 2H), 9.15 (dd, J = 5.2, 1.2 Hz, 
2H), 9.01 (s, 1H), 8.62 (m, 4H), 8.41 (d, J = 2.9 Hz,  2H), 8.37 (dd, J = 6.4, 3.2 Hz, 2H), 8.13 
(dd, J = 9.4, 4.0 Hz,  2H), 7.92 (m, 2H), 6.83 (d, J =  2.5 Hz, 2H), 6.63 (d, J = 8.1 Hz, 2H), 












[Ru(tpm)Cldppn][PF6] (204 mg, 0.186 mmol) and AgNO3 (2.1eq, 87 mg, 0.512 mmol) were 
placed in a 1:1 mixture of ethanol and water (100 mL) and heated to reflux for 2 hours. The 
solution was allowed to cool and filtered through celite to remove the AgCl precipitate. The 
filtrate was returned to the reaction vessel alongside with (734 mg, 2.46 mmol) L1 ligand and 
the solution reflux for 72 hours. The solution was allowed to cool, poured into an excess of 
saturated solution of NH4PF6 then the precipitate was collected by centrifuging and washed 
with water and diethyl ether before being dried under vacuum. 
 
 
Mass (Yield): 0.130 g (63.7 %). 




H NMR (400 MHz, MeOD): δH = 9.90 (d, J = 8.0 Hz, 2H), 9.25 (s, 1H), 9.20 (m, 2H), 9.10 
(d, J = 5.3 Hz, 2H), 8.90 (m, 2H), 8.74 (m, 2H), 8.42 (dd, J = 6.5, 3.1 Hz, 4H),  8.10 (d, J = 
1.9 Hz, 2H), 7.90 (m, 4H), 7.34 (d, J = 6.2 Hz, 2H), 6.84 (m, 4H), 6.43 (m, 2H), 6.25 (m, 










[Ru(tpm)Cldppn][PF6] (45 mg, 0.054 mmol) and AgNO3 (2.1eq, 75 mg, 0.441 mmol) were 
placed in a 1:1 mixture of ethanol and water (80 mL) and heated to reflux for 2 hours. The 
solution was allowed to cool and filtered through celite to remove the AgCl precipitate. The 
filtrate was returned to the reaction vessel. [(tpm)Ru(dppn)(L1)][PF6]2 (140 mg, 0.113 mmol) 
in acetone (20 ml) was added and the solution reflux for 72 hours. The solution was allowed 
to cool, poured into an excess of saturated solution of NH4PF6 then the precipitate was 




Mass (Yield): 0.042 g (30 %). 




H NMR (400 MHz, CD3CN): δH = 9.93 (d, J = 11.9 Hz, 4H), 9.23 (s, 2H), 8.93 (dd, J = 
4.36, 3.05 Hz, 4H), 8.63 (m, 6H), 8.46 (dd, J = 12, 7.0 Hz, 4H), 8.16 (m, 4H), 7.96 (m, 6H), 
7.89 (m, 4H), 7.24 (d, J = 7.4 Hz, 4H), 6.80 (t, J = 2.5 Hz, 8H), 6.43 (m, 4H), 6.25 (m, 2H), 
































[Ru(tpm)Cldppn][PF6] (45 mg, 0.054 mmol) and AgNO3 (2.1eq, 75 mg, 0.441 mmol) were 
placed in a 1:1 mixture of ethanol and water (80 mL) and heated to reflux for 2 hours. The 
solution was allowed to cool and filtered through celite to remove the AgCl precipitate. The 
filtrate was returned to the reaction vessel. [(tpm)Ru(dppz)(L1)]Cl2 (200 mg, 0.206 mmol) in 
ethanol and water (15 mL) was added and the solution reflux for 72 hours. The solution was 
allowed to cool, poured into an excess of saturated solution of NH4PF6 then the precipitate 




Mass (Yield): 0.110 g (68.7 %). 




H NMR (400 MHz, CD3CN): δH = 10.08 (s, 2H), 9.92 (dd, J = 7.2, 6.4 Hz, 4H), 9.22 (dd, J 
= 6.4, 4.6 Hz, 4H), 9.08 (dd, J = 5.4, 1.1 Hz, 4H), 8.62 (t, J = 3.4 Hz, 4H), 8.38 (d, J = 2.7 Hz, 
2H), 8.19 (m, 6H), 8.04 (dd, J = 8.2, 5.4 Hz, 4H), 7.45 (dd, J = 6.7 Hz, 4H), 7.39 (m, 6H), 
6.92 (t, J = 2.5 Hz, 4H), 6.74 (m, 4H), 6.29 (m, 2H), 4.28 (s, 4H), 3.17 (m, 4H), 2.90 (t, J = 
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